<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Mol Psychiatry</journal-id><journal-title-group><journal-title>Molecular Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1359-4184</issn><issn pub-type="epub">1476-5578</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39633006</article-id><article-id pub-id-type="pmc">PMC12092188</article-id>
<article-id pub-id-type="publisher-id">2838</article-id><article-id pub-id-type="doi">10.1038/s41380-024-02838-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>X&#x02010;chromosome-wide association study for Alzheimer&#x02019;s disease</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name><surname>Le Borgne</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name><surname>Gomez</surname><given-names>Lissette</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6083-2402</contrib-id><name><surname>Heikkinen</surname><given-names>Sami</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8944-1771</contrib-id><name><surname>Amin</surname><given-names>Najaf</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8658-3790</contrib-id><name><surname>Ahmad</surname><given-names>Shahzad</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Choi</surname><given-names>Seung Hoan</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3409-1110</contrib-id><name><surname>Bis</surname><given-names>Joshua</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Grenier-Boley</surname><given-names>Benjamin</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rodriguez</surname><given-names>Omar Garcia</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0009-0006-3309-6856</contrib-id><name><surname>Kleineidam</surname><given-names>Luca</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3923-6016</contrib-id><name><surname>Young</surname><given-names>Juan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3998-599X</contrib-id><name><surname>Tripathi</surname><given-names>Kumar Parijat</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Lily</given-names></name><xref ref-type="aff" rid="Aff11">11</xref></contrib><contrib contrib-type="author"><name><surname>Varma</surname><given-names>Achintya</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1395-8571</contrib-id><name><surname>Campos-Martin</surname><given-names>Rafael</given-names></name><xref ref-type="aff" rid="Aff10">10</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1606-8643</contrib-id><name><surname>van der Lee</surname><given-names>Sven</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff13">13</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7321-8575</contrib-id><name><surname>Damotte</surname><given-names>Vincent</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2148-381X</contrib-id><name><surname>de Rojas</surname><given-names>Itziar</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><name><surname>Palmal</surname><given-names>Sagnik</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" id="IAu1"><collab>EADB, GR@ACE, DEGESCO, EADI, GERAD, DemGene, FinnGen, ADGC, CHARGE</collab></contrib><contrib contrib-type="author"><name><surname>Lipton</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="Aff16">16</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0705-3696</contrib-id><name><surname>Reiman</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="Aff17">17</xref><xref ref-type="aff" rid="Aff18">18</xref><xref ref-type="aff" rid="Aff19">19</xref><xref ref-type="aff" rid="Aff20">20</xref></contrib><contrib contrib-type="author"><name><surname>McKee</surname><given-names>Ann</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff22">22</xref></contrib><contrib contrib-type="author"><name><surname>De Jager</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="Aff23">23</xref><xref ref-type="aff" rid="Aff24">24</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9729-6519</contrib-id><name><surname>Bush</surname><given-names>William</given-names></name><xref ref-type="aff" rid="Aff25">25</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4777-1502</contrib-id><name><surname>Small</surname><given-names>Scott</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff27">27</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3153-502X</contrib-id><name><surname>Levey</surname><given-names>Allan</given-names></name><xref ref-type="aff" rid="Aff28">28</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1376-8532</contrib-id><name><surname>Saykin</surname><given-names>Andrew</given-names></name><xref ref-type="aff" rid="Aff29">29</xref><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Foroud</surname><given-names>Tatiana</given-names></name><xref ref-type="aff" rid="Aff30">30</xref></contrib><contrib contrib-type="author"><name><surname>Albert</surname><given-names>Marilyn</given-names></name><xref ref-type="aff" rid="Aff31">31</xref></contrib><contrib contrib-type="author"><name><surname>Hyman</surname><given-names>Bradley</given-names></name><xref ref-type="aff" rid="Aff32">32</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8178-6601</contrib-id><name><surname>Petersen</surname><given-names>Ronald</given-names></name><xref ref-type="aff" rid="Aff33">33</xref></contrib><contrib contrib-type="author"><name><surname>Younkin</surname><given-names>Steven</given-names></name><xref ref-type="aff" rid="Aff34">34</xref></contrib><contrib contrib-type="author"><name><surname>Sano</surname><given-names>Mary</given-names></name><xref ref-type="aff" rid="Aff35">35</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3379-8966</contrib-id><name><surname>Wisniewski</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff36">36</xref><xref ref-type="aff" rid="Aff37">37</xref></contrib><contrib contrib-type="author"><name><surname>Vassar</surname><given-names>Robert</given-names></name><xref ref-type="aff" rid="Aff38">38</xref><xref ref-type="aff" rid="Aff39">39</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9482-1752</contrib-id><name><surname>Schneider</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="Aff40">40</xref><xref ref-type="aff" rid="Aff41">41</xref><xref ref-type="aff" rid="Aff42">42</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1198-9240</contrib-id><name><surname>Henderson</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="Aff43">43</xref><xref ref-type="aff" rid="Aff44">44</xref></contrib><contrib contrib-type="author"><name><surname>Roberson</surname><given-names>Erik</given-names></name><xref ref-type="aff" rid="Aff45">45</xref></contrib><contrib contrib-type="author"><name><surname>DeCarli</surname><given-names>Charles</given-names></name><xref ref-type="aff" rid="Aff46">46</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2324-6911</contrib-id><name><surname>LaFerla</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="Aff47">47</xref></contrib><contrib contrib-type="author"><name><surname>Brewer</surname><given-names>James</given-names></name><xref ref-type="aff" rid="Aff48">48</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2948-7230</contrib-id><name><surname>Swerdlow</surname><given-names>Russell</given-names></name><xref ref-type="aff" rid="Aff49">49</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8139-6400</contrib-id><name><surname>Van Eldik</surname><given-names>Linda</given-names></name><xref ref-type="aff" rid="Aff50">50</xref></contrib><contrib contrib-type="author"><name><surname>Hamilton-Nelson</surname><given-names>Kara</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Paulson</surname><given-names>Henry</given-names></name><xref ref-type="aff" rid="Aff51">51</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9621-2942</contrib-id><name><surname>Naj</surname><given-names>Adam</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8546-8256</contrib-id><name><surname>Lopez</surname><given-names>Oscar</given-names></name><xref ref-type="aff" rid="Aff53">53</xref></contrib><contrib contrib-type="author"><name><surname>Chui</surname><given-names>Helena</given-names></name><xref ref-type="aff" rid="Aff54">54</xref></contrib><contrib contrib-type="author"><name><surname>Crane</surname><given-names>Paul</given-names></name><xref ref-type="aff" rid="Aff55">55</xref></contrib><contrib contrib-type="author"><name><surname>Grabowski</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff56">56</xref><xref ref-type="aff" rid="Aff57">57</xref></contrib><contrib contrib-type="author"><name><surname>Kukull</surname><given-names>Walter</given-names></name><xref ref-type="aff" rid="Aff58">58</xref></contrib><contrib contrib-type="author"><name><surname>Asthana</surname><given-names>Sanjay</given-names></name><xref ref-type="aff" rid="Aff59">59</xref><xref ref-type="aff" rid="Aff60">60</xref><xref ref-type="aff" rid="Aff61">61</xref></contrib><contrib contrib-type="author"><name><surname>Craft</surname><given-names>Suzanne</given-names></name><xref ref-type="aff" rid="Aff62">62</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8188-3092</contrib-id><name><surname>Strittmatter</surname><given-names>Stephen</given-names></name><xref ref-type="aff" rid="Aff63">63</xref></contrib><contrib contrib-type="author"><name><surname>Cruchaga</surname><given-names>Carlos</given-names></name><xref ref-type="aff" rid="Aff64">64</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0896-0749</contrib-id><name><surname>Leverenz</surname><given-names>James</given-names></name><xref ref-type="aff" rid="Aff65">65</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0576-2472</contrib-id><name><surname>Goate</surname><given-names>Alison</given-names></name><xref ref-type="aff" rid="Aff66">66</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3453-1438</contrib-id><name><surname>Kamboh</surname><given-names>M. Ilyas</given-names></name><xref ref-type="aff" rid="Aff53">53</xref><xref ref-type="aff" rid="Aff67">67</xref></contrib><contrib contrib-type="author"><name><surname>George-Hyslop</surname><given-names>Peter St</given-names></name><xref ref-type="aff" rid="Aff68">68</xref><xref ref-type="aff" rid="Aff69">69</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8055-2187</contrib-id><name><surname>Valladares</surname><given-names>Otto</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6064-5420</contrib-id><name><surname>Kuzma</surname><given-names>Amanda</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name><surname>Cantwell</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><name><surname>Riemenschneider</surname><given-names>Matthias</given-names></name><xref ref-type="aff" rid="Aff70">70</xref></contrib><contrib contrib-type="author"><name><surname>Morris</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff71">71</xref><xref ref-type="aff" rid="Aff72">72</xref></contrib><contrib contrib-type="author"><name><surname>Slifer</surname><given-names>Susan</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4901-9955</contrib-id><name><surname>Dalmasso</surname><given-names>Carolina</given-names></name><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff73">73</xref></contrib><contrib contrib-type="author"><name><surname>Castillo</surname><given-names>Atahualpa</given-names></name><xref ref-type="aff" rid="Aff74">74</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3835-9639</contrib-id><name><surname>K&#x000fc;&#x000e7;&#x000fc;kali</surname><given-names>Fahri</given-names></name><xref ref-type="aff" rid="Aff75">75</xref><xref ref-type="aff" rid="Aff76">76</xref></contrib><contrib contrib-type="author"><name><surname>Peters</surname><given-names>Oliver</given-names></name><xref ref-type="aff" rid="Aff77">77</xref><xref ref-type="aff" rid="Aff78">78</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9540-8700</contrib-id><name><surname>Schneider</surname><given-names>Anja</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff79">79</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0654-387X</contrib-id><name><surname>Dichgans</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff80">80</xref><xref ref-type="aff" rid="Aff81">81</xref><xref ref-type="aff" rid="Aff82">82</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1432-313X</contrib-id><name><surname>Rujescu</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="Aff83">83</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1759-6990</contrib-id><name><surname>Scherbaum</surname><given-names>Norbert</given-names></name><xref ref-type="aff" rid="Aff84">84</xref></contrib><contrib contrib-type="author"><name><surname>Deckert</surname><given-names>J&#x000fc;rgen</given-names></name><xref ref-type="aff" rid="Aff85">85</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4321-6090</contrib-id><name><surname>Riedel-Heller</surname><given-names>Steffi</given-names></name><xref ref-type="aff" rid="Aff86">86</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9009-2356</contrib-id><name><surname>Hausner</surname><given-names>Lucrezia</given-names></name><xref ref-type="aff" rid="Aff87">87</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4068-8578</contrib-id><name><surname>Molina-Porcel</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff88">88</xref><xref ref-type="aff" rid="Aff89">89</xref></contrib><contrib contrib-type="author"><name><surname>D&#x000fc;zel</surname><given-names>Emrah</given-names></name><xref ref-type="aff" rid="Aff90">90</xref><xref ref-type="aff" rid="Aff91">91</xref></contrib><contrib contrib-type="author"><name><surname>Grimmer</surname><given-names>Timo</given-names></name><xref ref-type="aff" rid="Aff92">92</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1492-5330</contrib-id><name><surname>Wiltfang</surname><given-names>Jens</given-names></name><xref ref-type="aff" rid="Aff93">93</xref><xref ref-type="aff" rid="Aff94">94</xref><xref ref-type="aff" rid="Aff95">95</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1057-465X</contrib-id><name><surname>Heilmann-Heimbach</surname><given-names>Stefanie</given-names></name><xref ref-type="aff" rid="Aff96">96</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0072-5410</contrib-id><name><surname>Moebus</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="Aff97">97</xref></contrib><contrib contrib-type="author"><name><surname>Tegos</surname><given-names>Thomas</given-names></name><xref ref-type="aff" rid="Aff98">98</xref></contrib><contrib contrib-type="author"><name><surname>Scarmeas</surname><given-names>Nikolaos</given-names></name><xref ref-type="aff" rid="Aff99">99</xref><xref ref-type="aff" rid="Aff100">100</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2656-8748</contrib-id><name><surname>Dols-Icardo</surname><given-names>Oriol</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff101">101</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5200-3164</contrib-id><name><surname>Moreno</surname><given-names>Fermin</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff102">102</xref><xref ref-type="aff" rid="Aff103">103</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9111-1712</contrib-id><name><surname>P&#x000e9;rez-Tur</surname><given-names>Jordi</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff104">104</xref><xref ref-type="aff" rid="Aff105">105</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6477-1117</contrib-id><name><surname>Bullido</surname><given-names>Mar&#x000ed;a J.</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff106">106</xref><xref ref-type="aff" rid="Aff107">107</xref><xref ref-type="aff" rid="Aff108">108</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7493-8777</contrib-id><name><surname>Pastor</surname><given-names>Pau</given-names></name><xref ref-type="aff" rid="Aff109">109</xref><xref ref-type="aff" rid="Aff110">110</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;nchez-Valle</surname><given-names>Raquel</given-names></name><xref ref-type="aff" rid="Aff111">111</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1916-2523</contrib-id><name><surname>&#x000c1;lvarez</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="Aff112">112</xref><xref ref-type="aff" rid="Aff113">113</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2617-3009</contrib-id><name><surname>Boada</surname><given-names>Merc&#x000e8;</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0125-5403</contrib-id><name><surname>Garc&#x000ed;a-Gonz&#x000e1;lez</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1191-5893</contrib-id><name><surname>Puerta</surname><given-names>Raquel</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1656-302X</contrib-id><name><surname>Mir</surname><given-names>Pablo</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff114">114</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4932-7429</contrib-id><name><surname>Real</surname><given-names>Luis M.</given-names></name><xref ref-type="aff" rid="Aff115">115</xref><xref ref-type="aff" rid="Aff116">116</xref></contrib><contrib contrib-type="author"><name><surname>Pi&#x000f1;ol-Ripoll</surname><given-names>Gerard</given-names></name><xref ref-type="aff" rid="Aff117">117</xref><xref ref-type="aff" rid="Aff118">118</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2951-6644</contrib-id><name><surname>Garc&#x000ed;a-Alberca</surname><given-names>Jose Mar&#x000ed;a</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff119">119</xref></contrib><contrib contrib-type="author"><name><surname>Royo</surname><given-names>Jose Lu&#x000ed;s</given-names></name><xref ref-type="aff" rid="Aff116">116</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7742-677X</contrib-id><name><surname>Rodriguez-Rodriguez</surname><given-names>Eloy</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff120">120</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2785-9937</contrib-id><name><surname>Soininen</surname><given-names>Hilkka</given-names></name><xref ref-type="aff" rid="Aff121">121</xref></contrib><contrib contrib-type="author"><name><surname>de Mendon&#x000e7;a</surname><given-names>Alexandre</given-names></name><xref ref-type="aff" rid="Aff122">122</xref></contrib><contrib contrib-type="author"><name><surname>Mehrabian</surname><given-names>Shima</given-names></name><xref ref-type="aff" rid="Aff123">123</xref></contrib><contrib contrib-type="author"><name><surname>Traykov</surname><given-names>Latchezar</given-names></name><xref ref-type="aff" rid="Aff123">123</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1080-3726</contrib-id><name><surname>Hort</surname><given-names>Jakub</given-names></name><xref ref-type="aff" rid="Aff124">124</xref></contrib><contrib contrib-type="author"><name><surname>Vyhnalek</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff124">124</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3484-9531</contrib-id><name><surname>Thomassen</surname><given-names>Jesper Qvist</given-names></name><xref ref-type="aff" rid="Aff125">125</xref></contrib><contrib contrib-type="author"><name><surname>Pijnenburg</surname><given-names>Yolande A. L.</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7688-3087</contrib-id><name><surname>Holstege</surname><given-names>Henne</given-names></name><xref ref-type="aff" rid="Aff12">12</xref><xref ref-type="aff" rid="Aff126">126</xref></contrib><contrib contrib-type="author"><name><surname>van Swieten</surname><given-names>John</given-names></name><xref ref-type="aff" rid="Aff127">127</xref></contrib><contrib contrib-type="author"><name><surname>Ramakers</surname><given-names>Inez</given-names></name><xref ref-type="aff" rid="Aff128">128</xref></contrib><contrib contrib-type="author"><name><surname>Verhey</surname><given-names>Frans</given-names></name><xref ref-type="aff" rid="Aff128">128</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1046-6408</contrib-id><name><surname>Scheltens</surname><given-names>Philip</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><name><surname>Graff</surname><given-names>Caroline</given-names></name><xref ref-type="aff" rid="Aff129">129</xref></contrib><contrib contrib-type="author"><name><surname>Papenberg</surname><given-names>Goran</given-names></name><xref ref-type="aff" rid="Aff130">130</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3423-2021</contrib-id><name><surname>Giedraitis</surname><given-names>Vilmantas</given-names></name><xref ref-type="aff" rid="Aff131">131</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8789-5676</contrib-id><name><surname>Boland</surname><given-names>Anne</given-names></name><xref ref-type="aff" rid="Aff132">132</xref></contrib><contrib contrib-type="author"><name><surname>Deleuze</surname><given-names>Jean-Fran&#x000e7;ois</given-names></name><xref ref-type="aff" rid="Aff132">132</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9391-7800</contrib-id><name><surname>Nicolas</surname><given-names>Gael</given-names></name><xref ref-type="aff" rid="Aff133">133</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2442-4476</contrib-id><name><surname>Dufouil</surname><given-names>Carole</given-names></name><xref ref-type="aff" rid="Aff134">134</xref><xref ref-type="aff" rid="Aff135">135</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9880-9788</contrib-id><name><surname>Pasquier</surname><given-names>Florence</given-names></name><xref ref-type="aff" rid="Aff136">136</xref></contrib><contrib contrib-type="author"><name><surname>Hanon</surname><given-names>Olivier</given-names></name><xref ref-type="aff" rid="Aff137">137</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8675-7968</contrib-id><name><surname>Debette</surname><given-names>St&#x000e9;phanie</given-names></name><xref ref-type="aff" rid="Aff138">138</xref><xref ref-type="aff" rid="Aff139">139</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8505-7265</contrib-id><name><surname>Gr&#x000fc;nblatt</surname><given-names>Edna</given-names></name><xref ref-type="aff" rid="Aff140">140</xref><xref ref-type="aff" rid="Aff141">141</xref><xref ref-type="aff" rid="Aff142">142</xref></contrib><contrib contrib-type="author"><name><surname>Popp</surname><given-names>Julius</given-names></name><xref ref-type="aff" rid="Aff143">143</xref><xref ref-type="aff" rid="Aff144">144</xref><xref ref-type="aff" rid="Aff145">145</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7691-1957</contrib-id><name><surname>Ghidoni</surname><given-names>Roberta</given-names></name><xref ref-type="aff" rid="Aff146">146</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-9284-5953</contrib-id><name><surname>Galimberti</surname><given-names>Daniela</given-names></name><xref ref-type="aff" rid="Aff147">147</xref><xref ref-type="aff" rid="Aff148">148</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0615-3580</contrib-id><name><surname>Arosio</surname><given-names>Beatrice</given-names></name><xref ref-type="aff" rid="Aff149">149</xref><xref ref-type="aff" rid="Aff150">150</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0729-5246</contrib-id><name><surname>Mecocci</surname><given-names>Patrizia</given-names></name><xref ref-type="aff" rid="Aff151">151</xref><xref ref-type="aff" rid="Aff152">152</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8524-0315</contrib-id><name><surname>Solfrizzi</surname><given-names>Vincenzo</given-names></name><xref ref-type="aff" rid="Aff153">153</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5722-3967</contrib-id><name><surname>Parnetti</surname><given-names>Lucilla</given-names></name><xref ref-type="aff" rid="Aff154">154</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7415-7607</contrib-id><name><surname>Squassina</surname><given-names>Alessio</given-names></name><xref ref-type="aff" rid="Aff155">155</xref></contrib><contrib contrib-type="author"><name><surname>Tremolizzo</surname><given-names>Lucio</given-names></name><xref ref-type="aff" rid="Aff156">156</xref></contrib><contrib contrib-type="author"><name><surname>Borroni</surname><given-names>Barbara</given-names></name><xref ref-type="aff" rid="Aff157">157</xref><xref ref-type="aff" rid="Aff158">158</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9338-9040</contrib-id><name><surname>Nacmias</surname><given-names>Benedetta</given-names></name><xref ref-type="aff" rid="Aff159">159</xref><xref ref-type="aff" rid="Aff160">160</xref></contrib><contrib contrib-type="author"><name><surname>Spallazzi</surname><given-names>Marco</given-names></name><xref ref-type="aff" rid="Aff161">161</xref></contrib><contrib contrib-type="author"><name><surname>Seripa</surname><given-names>Davide</given-names></name><xref ref-type="aff" rid="Aff162">162</xref></contrib><contrib contrib-type="author"><name><surname>Rainero</surname><given-names>Innocenzo</given-names></name><xref ref-type="aff" rid="Aff163">163</xref></contrib><contrib contrib-type="author"><name><surname>Daniele</surname><given-names>Antonio</given-names></name><xref ref-type="aff" rid="Aff164">164</xref><xref ref-type="aff" rid="Aff165">165</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1432-0078</contrib-id><name><surname>Boss&#x000f9;</surname><given-names>Paola</given-names></name><xref ref-type="aff" rid="Aff166">166</xref></contrib><contrib contrib-type="author"><name><surname>Masullo</surname><given-names>Carlo</given-names></name><xref ref-type="aff" rid="Aff167">167</xref></contrib><contrib contrib-type="author"><name><surname>Rossi</surname><given-names>Giacomina</given-names></name><xref ref-type="aff" rid="Aff168">168</xref></contrib><contrib contrib-type="author"><name><surname>Jessen</surname><given-names>Frank</given-names></name><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff169">169</xref><xref ref-type="aff" rid="Aff170">170</xref></contrib><contrib contrib-type="author"><name><surname>Fernandez</surname><given-names>Victoria</given-names></name><xref ref-type="aff" rid="Aff14">14</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7542-1139</contrib-id><name><surname>Kehoe</surname><given-names>Patrick Gavin</given-names></name><xref ref-type="aff" rid="Aff171">171</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4084-5027</contrib-id><name><surname>Frikke-Schmidt</surname><given-names>Ruth</given-names></name><xref ref-type="aff" rid="Aff125">125</xref><xref ref-type="aff" rid="Aff172">172</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2072-8010</contrib-id><name><surname>Tsolaki</surname><given-names>Magda</given-names></name><xref ref-type="aff" rid="Aff98">98</xref><xref ref-type="aff" rid="Aff173">173</xref></contrib><contrib contrib-type="author"><name><surname>S&#x000e1;nchez-Juan</surname><given-names>Pascual</given-names></name><xref ref-type="aff" rid="Aff15">15</xref><xref ref-type="aff" rid="Aff174">174</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0283-2332</contrib-id><name><surname>Sleegers</surname><given-names>Kristel</given-names></name><xref ref-type="aff" rid="Aff75">75</xref><xref ref-type="aff" rid="Aff76">76</xref></contrib><contrib contrib-type="author"><name><surname>Ingelsson</surname><given-names>Martin</given-names></name><xref ref-type="aff" rid="Aff131">131</xref><xref ref-type="aff" rid="Aff175">175</xref><xref ref-type="aff" rid="Aff176">176</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4351-4728</contrib-id><name><surname>Haines</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="Aff177">177</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-5533-4225</contrib-id><name><surname>Farrer</surname><given-names>Lindsay</given-names></name><xref ref-type="aff" rid="Aff21">21</xref><xref ref-type="aff" rid="Aff178">178</xref><xref ref-type="aff" rid="Aff179">179</xref><xref ref-type="aff" rid="Aff180">180</xref><xref ref-type="aff" rid="Aff181">181</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6519-9696</contrib-id><name><surname>Mayeux</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="Aff26">26</xref><xref ref-type="aff" rid="Aff182">182</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Li-San</given-names></name><xref ref-type="aff" rid="Aff183">183</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3885-1199</contrib-id><name><surname>Sims</surname><given-names>Rebecca</given-names></name><xref ref-type="aff" rid="Aff74">74</xref></contrib><contrib contrib-type="author"><name><surname>DeStefano</surname><given-names>Anita</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Schellenberg</surname><given-names>Gerard D.</given-names></name><xref ref-type="aff" rid="Aff52">52</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6135-2622</contrib-id><name><surname>Seshadri</surname><given-names>Sudha</given-names></name><xref ref-type="aff" rid="Aff184">184</xref><xref ref-type="aff" rid="Aff185">185</xref><xref ref-type="aff" rid="Aff186">186</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9088-234X</contrib-id><name><surname>Amouyel</surname><given-names>Philippe</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4069-0259</contrib-id><name><surname>Williams</surname><given-names>Julie</given-names></name><xref ref-type="aff" rid="Aff74">74</xref><xref ref-type="aff" rid="Aff187">187</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8766-6224</contrib-id><name><surname>van der Flier</surname><given-names>Wiesje</given-names></name><xref ref-type="aff" rid="Aff12">12</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-4991-763X</contrib-id><name><surname>Ramirez</surname><given-names>Alfredo</given-names></name><xref ref-type="aff" rid="Aff8">8</xref><xref ref-type="aff" rid="Aff9">9</xref><xref ref-type="aff" rid="Aff10">10</xref><xref ref-type="aff" rid="Aff188">188</xref><xref ref-type="aff" rid="Aff189">189</xref></contrib><contrib contrib-type="author"><name><surname>Pericak-Vance</surname><given-names>Margaret</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff190">190</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4461-3568</contrib-id><name><surname>Andreassen</surname><given-names>Ole A.</given-names></name><xref ref-type="aff" rid="Aff191">191</xref><xref ref-type="aff" rid="Aff192">192</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2374-9204</contrib-id><name><surname>Van Duijn</surname><given-names>Cornelia</given-names></name><xref ref-type="aff" rid="Aff4">4</xref><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Hiltunen</surname><given-names>Mikko</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2633-2495</contrib-id><name><surname>Ruiz</surname><given-names>Agust&#x000ed;n</given-names></name><xref ref-type="aff" rid="Aff14">14</xref><xref ref-type="aff" rid="Aff15">15</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2871-3603</contrib-id><name><surname>Dupuis</surname><given-names>Jos&#x000e9;e</given-names></name><xref ref-type="aff" rid="Aff6">6</xref><xref ref-type="aff" rid="Aff193">193</xref></contrib><contrib contrib-type="author"><name><surname>Martin</surname><given-names>Eden</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff190">190</xref><xref ref-type="aff" rid="Aff194">194</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0829-7817</contrib-id><name><surname>Lambert</surname><given-names>Jean-Charles</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Kunkle</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1240-7874</contrib-id><name><surname>Bellenguez</surname><given-names>C&#x000e9;line</given-names></name><address><email>celine.bellenguez@pasteur-lille.fr</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.523099.4</institution-id><institution-id institution-id-type="ISNI">0000 0005 1237 6862</institution-id><institution>Univ. Lille, Inserm, CHU Lille, Institut Pasteur de Lille, </institution><institution>LabEx DISTALZ - U1167-RID-AGE Facteurs de Risque et D&#x000e9;terminants Mol&#x000e9;culaires des Maladies Li&#x000e9;es au Vieillissement, </institution></institution-wrap>Lille, France </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>The John P. Hussman Institute for Human Genomics, </institution><institution>University of Miami, </institution></institution-wrap>Miami, FL USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cyydd11</institution-id><institution-id institution-id-type="GRID">grid.9668.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 2490</institution-id><institution>Institute of Biomedicine, </institution><institution>University of Eastern Finland, </institution></institution-wrap>Kuopio, Finland </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/052gg0110</institution-id><institution-id institution-id-type="GRID">grid.4991.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8948</institution-id><institution>Nuffield Department of Population Health Oxford University, </institution></institution-wrap>Oxford, UK </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018906e22</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 992X</institution-id><institution>Department of Epidemiology, </institution><institution>Erasmus MC, </institution></institution-wrap>Rotterdam, The Netherlands </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Biostatistics, </institution><institution>Boston University School of Public Health, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Medicine, Cardiovascular Health Research Unit, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/041nas322</institution-id><institution-id institution-id-type="GRID">grid.10388.32</institution-id><institution-id institution-id-type="ISNI">0000 0001 2240 3300</institution-id><institution>Department of Old Age Psychiatry and Cognitive Disorders, University Hospital Bonn, </institution><institution>University of Bonn, </institution></institution-wrap>Bonn, Germany </aff><aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043j0f473</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>German Center for Neurodegenerative Diseases (DZNE), </institution></institution-wrap>Bonn, Germany </aff><aff id="Aff10"><label>10</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rcxh774</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Division of Neurogenetics and Molecular Psychiatry, Department of Psychiatry and Psychotherapy, University of Cologne, </institution><institution>Medical Faculty, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff11"><label>11</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>Department of Public Health Sciences, </institution><institution>University of Miami Miller School of Medicine, </institution></institution-wrap>Miami, FL USA </aff><aff id="Aff12"><label>12</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05grdyy37</institution-id><institution-id institution-id-type="GRID">grid.509540.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 6880 3010</institution-id><institution>Alzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, </institution><institution>Amsterdam UMC, </institution></institution-wrap>Amsterdam, The Netherlands </aff><aff id="Aff13"><label>13</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01x2d9f70</institution-id><institution-id institution-id-type="GRID">grid.484519.5</institution-id><institution>Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, </institution><institution>Vrije University, </institution></institution-wrap>Amsterdam, The Netherlands </aff><aff id="Aff14"><label>14</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00tse2b39</institution-id><institution-id institution-id-type="GRID">grid.410675.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2325 3084</institution-id><institution>Research Center and Memory Clinic, ACE Alzheimer Center Barcelona, </institution><institution>Universitat Internacional de Catalunya, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff15"><label>15</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00ca2c886</institution-id><institution-id institution-id-type="GRID">grid.413448.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9314 1427</institution-id><institution>CIBERNED, Network Center for Biomedical Research in Neurodegenerative Diseases, </institution><institution>National Institute of Health Carlos III, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff16"><label>16</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05cf8a891</institution-id><institution-id institution-id-type="GRID">grid.251993.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2179 1997</institution-id><institution>Department of Neurology, </institution><institution>Albert Einstein College of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff17"><label>17</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02hfpnk21</institution-id><institution-id institution-id-type="GRID">grid.250942.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0507 3225</institution-id><institution>Neurogenomics Division, </institution><institution>Translational Genomics Research Institute, </institution></institution-wrap>Phoenix, AZ USA </aff><aff id="Aff18"><label>18</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvnc278</institution-id><institution-id institution-id-type="ISNI">0000 0004 7862 1659</institution-id><institution>Arizona Alzheimer&#x02019;s Consortium, </institution></institution-wrap>Phoenix, AZ USA </aff><aff id="Aff19"><label>19</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/023jwkg52</institution-id><institution>Banner Alzheimer&#x02019;s Institute, </institution></institution-wrap>Phoenix, AZ USA </aff><aff id="Aff20"><label>20</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03m2x1q45</institution-id><institution-id institution-id-type="GRID">grid.134563.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2168 186X</institution-id><institution>Department of Psychiatry, </institution><institution>University of Arizona, </institution></institution-wrap>Phoenix, AZ USA </aff><aff id="Aff21"><label>21</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Neurology, </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff22"><label>22</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Pathology, </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff23"><label>23</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04b6nzv94</institution-id><institution-id institution-id-type="GRID">grid.62560.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 0378 8294</institution-id><institution>Program in Translational Neuro-Psychiatric Genomics, Institute for the Neurosciences, Department of Neurology &#x00026; Psychiatry, </institution><institution>Brigham and Women&#x02019;s Hospital and Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff24"><label>24</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05a0ya142</institution-id><institution-id institution-id-type="GRID">grid.66859.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0546 1623</institution-id><institution>Program in Medical and Population Genetics, </institution><institution>Broad Institute, </institution></institution-wrap>Cambridge, MA USA </aff><aff id="Aff25"><label>25</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/051fd9666</institution-id><institution-id institution-id-type="GRID">grid.67105.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2164 3847</institution-id><institution>Department of Epidemiology and Biostatistics, </institution><institution>Case Western Reserve University, </institution></institution-wrap>Cleveland, OH USA </aff><aff id="Aff26"><label>26</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>Taub Institute on Alzheimer&#x02019;s Disease and the Aging Brain, Department of Neurology, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff27"><label>27</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>Department of Neurology, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff28"><label>28</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03czfpz43</institution-id><institution-id institution-id-type="GRID">grid.189967.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7398</institution-id><institution>Department of Neurology, </institution><institution>Emory University, </institution></institution-wrap>Atlanta, GA USA </aff><aff id="Aff29"><label>29</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gxnyn08</institution-id><institution-id institution-id-type="GRID">grid.257413.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2287 3919</institution-id><institution>Department of Radiology, </institution><institution>Indiana University, </institution></institution-wrap>Indianapolis, IN USA </aff><aff id="Aff30"><label>30</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gxnyn08</institution-id><institution-id institution-id-type="GRID">grid.257413.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 2287 3919</institution-id><institution>Department of Medical and Molecular Genetics, </institution><institution>Indiana University, </institution></institution-wrap>Indianapolis, IN USA </aff><aff id="Aff31"><label>31</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00za53h95</institution-id><institution-id institution-id-type="GRID">grid.21107.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2171 9311</institution-id><institution>Department of Neurology, </institution><institution>Johns Hopkins University, </institution></institution-wrap>Baltimore, MD USA </aff><aff id="Aff32"><label>32</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/002pd6e78</institution-id><institution-id institution-id-type="GRID">grid.32224.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0386 9924</institution-id><institution>Department of Neurology, </institution><institution>Massachusetts General Hospital/Harvard Medical School, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff33"><label>33</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qp3tb03</institution-id><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution>Department of Neurology, </institution><institution>Mayo Clinic, </institution></institution-wrap>Rochester, MN USA </aff><aff id="Aff34"><label>34</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02qp3tb03</institution-id><institution-id institution-id-type="GRID">grid.66875.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 167X</institution-id><institution>Department of Neuroscience, </institution><institution>Mayo Clinic, </institution></institution-wrap>Jacksonville, FL USA </aff><aff id="Aff35"><label>35</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04a9tmd77</institution-id><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Psychiatry, </institution><institution>Mount Sinai School of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff36"><label>36</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0190ak572</institution-id><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>Center for Cognitive Neurology and Departments of Neurology, New York University, </institution><institution>School of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff37"><label>37</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0190ak572</institution-id><institution-id institution-id-type="GRID">grid.137628.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8753</institution-id><institution>Department of Psychiatry, </institution><institution>New York University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff38"><label>38</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/019t2rq07</institution-id><institution-id institution-id-type="GRID">grid.462972.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0466 9414</institution-id><institution>Cognitive Neurology and Alzheimer&#x02019;s Disease Center, </institution><institution>Northwestern University Feinberg School of Medicine, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff39"><label>39</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/019t2rq07</institution-id><institution-id institution-id-type="GRID">grid.462972.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 0466 9414</institution-id><institution>Department of Neurology, </institution><institution>Northwestern University Feinberg School of Medicine, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff40"><label>40</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01j7c0b24</institution-id><institution-id institution-id-type="GRID">grid.240684.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0705 3621</institution-id><institution>Department of Neurological Sciences, </institution><institution>Rush University Medical Center, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff41"><label>41</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01j7c0b24</institution-id><institution-id institution-id-type="GRID">grid.240684.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0705 3621</institution-id><institution>Rush Alzheimer&#x02019;s Disease Center, </institution><institution>Rush University Medical Center, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff42"><label>42</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01j7c0b24</institution-id><institution-id institution-id-type="GRID">grid.240684.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0705 3621</institution-id><institution>Department of Pathology (Neuropathology), </institution><institution>Rush University Medical Center, </institution></institution-wrap>Chicago, IL USA </aff><aff id="Aff43"><label>43</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>Department of Epidemiology and Population Health, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff44"><label>44</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f54p054</institution-id><institution-id institution-id-type="GRID">grid.168010.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8956</institution-id><institution>Department of Neurology &#x00026; Neurological Sciences, </institution><institution>Stanford University, </institution></institution-wrap>Stanford, CA USA </aff><aff id="Aff45"><label>45</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/008s83205</institution-id><institution-id institution-id-type="GRID">grid.265892.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0634 4187</institution-id><institution>Department of Neurology, </institution><institution>University of Alabama at Birmingham, </institution></institution-wrap>Birmingham, AL USA </aff><aff id="Aff46"><label>46</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05rrcem69</institution-id><institution-id institution-id-type="GRID">grid.27860.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9684</institution-id><institution>Department of Neurology, </institution><institution>University of California Davis, </institution></institution-wrap>Sacramento, CA USA </aff><aff id="Aff47"><label>47</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04gyf1771</institution-id><institution-id institution-id-type="GRID">grid.266093.8</institution-id><institution-id institution-id-type="ISNI">0000 0001 0668 7243</institution-id><institution>Department of Neurobiology and Behavior, </institution><institution>University of California Irvine, </institution></institution-wrap>Irvine, CA USA </aff><aff id="Aff48"><label>48</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0168r3w48</institution-id><institution-id institution-id-type="GRID">grid.266100.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2107 4242</institution-id><institution>Department of Neurosciences, </institution><institution>University of California San Diego, </institution></institution-wrap>La Jolla, CA USA </aff><aff id="Aff49"><label>49</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/036c9yv20</institution-id><institution-id institution-id-type="GRID">grid.412016.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2177 6375</institution-id><institution>University of Kansas Alzheimer&#x02019;s Disease Center, </institution><institution>University of Kansas Medical Center, </institution></institution-wrap>Kansas City, KS USA </aff><aff id="Aff50"><label>50</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02k3smh20</institution-id><institution-id institution-id-type="GRID">grid.266539.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8438</institution-id><institution>Sanders-Brown Center on Aging and University of Kentucky Alzheimer&#x02019;s Disease Research Center, Department of Neuroscience, </institution><institution>University of Kentucky, </institution></institution-wrap>Lexington, KY USA </aff><aff id="Aff51"><label>51</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00jmfr291</institution-id><institution-id institution-id-type="GRID">grid.214458.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7347</institution-id><institution>Michigan Alzheimer&#x02019;s Disease Center, Department of Neurology, </institution><institution>University of Michigan, </institution></institution-wrap>Ann Arbor, MI USA </aff><aff id="Aff52"><label>52</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b30xv10</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Penn Neurodegeneration Genomics Center, Department of Pathology and Laboratory Medicine, </institution><institution>University of Pennsylvania Perelman School of Medicine, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff53"><label>53</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01an3r305</institution-id><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>University of Pittsburgh Alzheimer&#x02019;s Disease Research Center, </institution></institution-wrap>Pittsburgh, PA USA </aff><aff id="Aff54"><label>54</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03taz7m60</institution-id><institution-id institution-id-type="GRID">grid.42505.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2156 6853</institution-id><institution>Department of Neurology, </institution><institution>University of Southern California, </institution></institution-wrap>Los Angeles, CA USA </aff><aff id="Aff55"><label>55</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Medicine, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff56"><label>56</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Neurology, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff57"><label>57</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Radiology, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff58"><label>58</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Epidemiology, </institution><institution>University of Washington, </institution></institution-wrap>Seattle, WA USA </aff><aff id="Aff59"><label>59</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01nh3sx96</institution-id><institution-id institution-id-type="GRID">grid.511190.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 7648 112X</institution-id><institution>Geriatric Research, Education and Clinical Center (GRECC), </institution><institution>University of Wisconsin, </institution></institution-wrap>Madison, WI USA </aff><aff id="Aff60"><label>60</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01y2jtd41</institution-id><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution>Department of Medicine, </institution><institution>University of Wisconsin, </institution></institution-wrap>Madison, WI USA </aff><aff id="Aff61"><label>61</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01y2jtd41</institution-id><institution-id institution-id-type="GRID">grid.14003.36</institution-id><institution-id institution-id-type="ISNI">0000 0001 2167 3675</institution-id><institution>Wisconsin Alzheimer&#x02019;s Disease Research Center, </institution></institution-wrap>Madison, WI USA </aff><aff id="Aff62"><label>62</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0207ad724</institution-id><institution-id institution-id-type="GRID">grid.241167.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2185 3318</institution-id><institution>Gerontology and Geriatric Medicine Center on Diabetes, Obesity, and Metabolism, </institution><institution>Wake Forest School of Medicine, </institution></institution-wrap>Winston-Salem, NC USA </aff><aff id="Aff63"><label>63</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03v76x132</institution-id><institution-id institution-id-type="GRID">grid.47100.32</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8710</institution-id><institution>Program in Cellular Neuroscience, Neurodegeneration &#x00026; Repair, </institution><institution>Yale University, </institution></institution-wrap>New Haven, CT USA </aff><aff id="Aff64"><label>64</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03x3g5467</institution-id><institution>Department of Psychiatry and Hope Center Program on Protein Aggregation and Neurodegeneration, </institution><institution>Washington University School of Medicine, </institution></institution-wrap>St. Louis, MO USA </aff><aff id="Aff65"><label>65</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03xjacd83</institution-id><institution-id institution-id-type="GRID">grid.239578.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0675 4725</institution-id><institution>Cleveland Clinic Lou Ruvo Center for Brain Health, </institution><institution>Cleveland Clinic, </institution></institution-wrap>Cleveland, OH USA </aff><aff id="Aff66"><label>66</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04a9tmd77</institution-id><institution-id institution-id-type="GRID">grid.59734.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0670 2351</institution-id><institution>Department of Neuroscience, </institution><institution>Mount Sinai School of Medicine, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff67"><label>67</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01an3r305</institution-id><institution-id institution-id-type="GRID">grid.21925.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9000</institution-id><institution>Department of Human Genetics, </institution><institution>University of Pittsburgh, </institution></institution-wrap>Pittsburgh, PA USA </aff><aff id="Aff68"><label>68</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/042xt5161</institution-id><institution-id institution-id-type="GRID">grid.231844.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0474 0428</institution-id><institution>Department of Medicine (Neurology), Tanz Centre for Research in Neurodegenerative Disease, Temerty Faculty of Medicine, University of Toronto, </institution><institution>and University Health Network, </institution></institution-wrap>Toronto, ON USA </aff><aff id="Aff69"><label>69</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01esghr10</institution-id><institution-id institution-id-type="GRID">grid.239585.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2285 2675</institution-id><institution>Taub Institute for Research on Alzheimer&#x02019;s Disease and the Aging Brain, Department of Neurology, Columbia University Irving Medical Center, </institution><institution>630 West 168th Street, </institution></institution-wrap>New York, NY 10032 USA </aff><aff id="Aff70"><label>70</label>Klinik f&#x000fc;r Psychiatrie und Psychotherapie, Saarbr&#x000fc;cken, Germany </aff><aff id="Aff71"><label>71</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Neurology, </institution><institution>Washington University, </institution></institution-wrap>St. Louis, MO USA </aff><aff id="Aff72"><label>72</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cvxb145</institution-id><institution-id institution-id-type="GRID">grid.34477.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 6657</institution-id><institution>Department of Pathology and Immunology, </institution><institution>Washington University, </institution></institution-wrap>St. Louis, MO USA </aff><aff id="Aff73"><label>73</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03cqe8w59</institution-id><institution-id institution-id-type="GRID">grid.423606.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1945 2152</institution-id><institution>Estudios en Neurociencias y Sistemas Complejos (ENyS) CONICET-HEC-UNAJ, </institution></institution-wrap>Buenos Aires, Argentina </aff><aff id="Aff74"><label>74</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03kk7td41</institution-id><institution-id institution-id-type="GRID">grid.5600.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 5670</institution-id><institution>Division of Psychological Medicine and Clinical Neuroscience, </institution><institution>School of Medicine, Cardiff University, </institution></institution-wrap>Wales, UK </aff><aff id="Aff75"><label>75</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/008x57b05</institution-id><institution-id institution-id-type="GRID">grid.5284.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0790 3681</institution-id><institution>Complex Genetics of Alzheimer&#x02019;s Disease Group, VIB Center for Molecular Neurology, </institution><institution>VIB, </institution></institution-wrap>Antwerp, Belgium </aff><aff id="Aff76"><label>76</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/008x57b05</institution-id><institution-id institution-id-type="GRID">grid.5284.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 0790 3681</institution-id><institution>Department of Biomedical Sciences, </institution><institution>University of Antwerp, </institution></institution-wrap>Antwerp, Belgium </aff><aff id="Aff77"><label>77</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043j0f473</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>German Center for Neurodegenerative Diseases (DZNE), </institution></institution-wrap>Berlin, Germany </aff><aff id="Aff78"><label>78</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01hcx6992</institution-id><institution-id institution-id-type="GRID">grid.7468.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 2248 7639</institution-id><institution>Charit&#x000e9;&#x02014;Universit&#x000e4;tsmedizin Berlin, Corporate Member of Freie Universit&#x000e4;t Berlin, Humboldt-Universit&#x000e4;t zu Berlin, and Berlin Institute of Health, </institution><institution>Institute of Psychiatry and Psychotherapy, </institution></institution-wrap>Hindenburgdamm 30, 12203 Berlin, Germany </aff><aff id="Aff79"><label>79</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xnwqx93</institution-id><institution-id institution-id-type="GRID">grid.15090.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8786 803X</institution-id><institution>Department for Neurodegenerative Diseases and Geriatric Psychiatry, </institution><institution>University Hospital Bonn, </institution></institution-wrap>Venusberg-Campus 1, 53127 Bonn, Germany </aff><aff id="Aff80"><label>80</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05591te55</institution-id><institution-id institution-id-type="GRID">grid.5252.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 973X</institution-id><institution>Institute for Stroke and Dementia Research (ISD), University Hospital, </institution><institution>LMU Munich, </institution></institution-wrap>Munich, Germany </aff><aff id="Aff81"><label>81</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043j0f473</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>German Center for Neurodegenerative Diseases (DZNE), </institution></institution-wrap>Munich, Germany </aff><aff id="Aff82"><label>82</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/025z3z560</institution-id><institution-id institution-id-type="GRID">grid.452617.3</institution-id><institution>Munich Cluster for Systems Neurology (SyNergy), </institution></institution-wrap>Munich, Germany </aff><aff id="Aff83"><label>83</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05gqaka33</institution-id><institution-id institution-id-type="GRID">grid.9018.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0679 2801</institution-id><institution>Martin-Luther-University Halle-Wittenberg, University Clinic and Outpatient Clinic for Psychiatry, </institution><institution>Psychotherapy and Psychosomatics, </institution></institution-wrap>Halle (Saale), Germany </aff><aff id="Aff84"><label>84</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04mz5ra38</institution-id><institution-id institution-id-type="GRID">grid.5718.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2187 5445</institution-id><institution>Department of Psychiatry and Psychotherapy, LVR-Klinikum Essen, University of Duisburg-Essen, Germany, </institution><institution>Medical Faculty, </institution></institution-wrap>Duisburg, Germany </aff><aff id="Aff85"><label>85</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03pvr2g57</institution-id><institution-id institution-id-type="GRID">grid.411760.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 1378 7891</institution-id><institution>Department of Psychiatry, Psychosomatics and Psychotherapy, Center of Mental Health, </institution><institution>University Hospital of W&#x000fc;rzburg, </institution></institution-wrap>W&#x000fc;rzburg, Germany </aff><aff id="Aff86"><label>86</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03s7gtk40</institution-id><institution-id institution-id-type="GRID">grid.9647.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 7669 9786</institution-id><institution>Institute of Social Medicine, Occupational Health and Public Health, </institution><institution>University of Leipzig, </institution></institution-wrap>04103 Leipzig, Germany </aff><aff id="Aff87"><label>87</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/038t36y30</institution-id><institution-id institution-id-type="GRID">grid.7700.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 4373</institution-id><institution>Department of Geriatric Psychiatry, Central Institute for Mental Health Mannheim, Faculty Mannheim, </institution><institution>University of Heidelberg, </institution></institution-wrap>Heidelberg, Germany </aff><aff id="Aff88"><label>88</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/021018s57</institution-id><institution-id institution-id-type="GRID">grid.5841.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id><institution>Alzheimer&#x02019;s Disease and Other Cognitive Disorders Unit, Neurology Service, Hospital Cl&#x000ed;nic of Barcelona, Fundaci&#x000f3; Recerca Clinic Barcelona- Institut d&#x02019;Investigacions Biom&#x000e8;diques August Pi i Sunyer (FRCB-IDIBAPS), </institution><institution>and University of Barcelona, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff89"><label>89</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02a2kzf50</institution-id><institution-id institution-id-type="GRID">grid.410458.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9635 9413</institution-id><institution>Neurological Tissue Bank-Biobank, </institution><institution>Hospital Clinic-FRCB-IDIBAPS, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff90"><label>90</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043j0f473</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>German Center for Neurodegenerative Diseases (DZNE), </institution></institution-wrap>Magdeburg, Germany </aff><aff id="Aff91"><label>91</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00ggpsq73</institution-id><institution-id institution-id-type="GRID">grid.5807.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 1018 4307</institution-id><institution>Institute of Cognitive Neurology and Dementia Research (IKND), </institution><institution>Otto-von-Guericke University, </institution></institution-wrap>Magdeburg, Germany </aff><aff id="Aff92"><label>92</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04jc43x05</institution-id><institution-id institution-id-type="GRID">grid.15474.33</institution-id><institution-id institution-id-type="ISNI">0000 0004 0477 2438</institution-id><institution>Center for Cognitive Disorders, Department of Psychiatry and Psychotherapy, Technical University of Munich, School of Medicine and Health, </institution><institution>Klinikum rechts der Isar, </institution></institution-wrap>Munich, Germany </aff><aff id="Aff93"><label>93</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/021ft0n22</institution-id><institution-id institution-id-type="GRID">grid.411984.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0482 5331</institution-id><institution>Department of Psychiatry and Psychotherapy, </institution><institution>University Medical Center Goettingen, </institution></institution-wrap>Goettingen, Germany </aff><aff id="Aff94"><label>94</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/043j0f473</institution-id><institution-id institution-id-type="GRID">grid.424247.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0438 0426</institution-id><institution>German Center for Neurodegenerative Diseases (DZNE), </institution></institution-wrap>Goettingen, Germany </aff><aff id="Aff95"><label>95</label>Medical Science Department, iBiMED, Aveiro, Portugal </aff><aff id="Aff96"><label>96</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xnwqx93</institution-id><institution-id institution-id-type="GRID">grid.15090.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8786 803X</institution-id><institution>Institute of Human Genetics, University of Bonn, </institution><institution>School of Medicine &#x00026; University Hospital Bonn, </institution></institution-wrap>Bonn, Germany </aff><aff id="Aff97"><label>97</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04mz5ra38</institution-id><institution-id institution-id-type="GRID">grid.5718.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2187 5445</institution-id><institution>Institute for Urban Public Health, </institution><institution>University Hospital of University Duisburg-Essen, </institution></institution-wrap>Essen, Germany </aff><aff id="Aff98"><label>98</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02j61yw88</institution-id><institution-id institution-id-type="GRID">grid.4793.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0945 7005</institution-id><institution>1st Department of Neurology, Medical school, </institution><institution>Aristotle University of Thessaloniki, </institution></institution-wrap>Thessaloniki, Makedonia Greece </aff><aff id="Aff99"><label>99</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>Taub Institute for Research in Alzheimer&#x02019;s Disease and the Aging Brain, The Gertrude H. Sergievsky Center, Depatment of Neurology, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff100"><label>100</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04gnjpq42</institution-id><institution-id institution-id-type="GRID">grid.5216.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 2155 0800</institution-id><institution>1st Department of Neurology, Aiginition Hospital, National and Kapodistrian University of Athens, </institution><institution>Medical School, </institution></institution-wrap>Athens, Greece </aff><aff id="Aff101"><label>101</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/059n1d175</institution-id><institution-id institution-id-type="GRID">grid.413396.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1768 8905</institution-id><institution>Sant Pau Memory Unit, Institut de Recerca Sant Pau (IR Sant Pau), Department of Neurology, </institution><institution>Hospital de la Santa Creu i Sant Pau, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff102"><label>102</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04fkwzm96</institution-id><institution-id institution-id-type="GRID">grid.414651.3</institution-id><institution>Department of Neurology, Hospital Universitario Donostia, </institution></institution-wrap>San Sebastian, Spain </aff><aff id="Aff103"><label>103</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01a2wsa50</institution-id><institution-id institution-id-type="GRID">grid.432380.e</institution-id><institution>Neurosciences Area, Instituto Biodonostia, </institution></institution-wrap>San Sebastian, Spain </aff><aff id="Aff104"><label>104</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05pq8vh42</institution-id><institution-id institution-id-type="GRID">grid.466828.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1793 8484</institution-id><institution>Unitat de Gen&#x000e8;tica Molecular, </institution><institution>Institut de Biomedicina de Val&#x000e8;ncia-CSIC, </institution></institution-wrap>Valencia, Spain </aff><aff id="Aff105"><label>105</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05n7v5997</institution-id><institution-id institution-id-type="GRID">grid.476458.c</institution-id><institution>Unidad Mixta de Neurologia Gen&#x000e8;tica, </institution><institution>Instituto de Investigaci&#x000f3;n Sanitaria La Fe, </institution></institution-wrap>Valencia, Spain </aff><aff id="Aff106"><label>106</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03v9e8t09</institution-id><institution-id institution-id-type="GRID">grid.465524.4</institution-id><institution>Centro de Biolog&#x000ed;a Molecular Severo Ochoa (UAM-CSIC), </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff107"><label>107</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01s1q0w69</institution-id><institution-id institution-id-type="GRID">grid.81821.32</institution-id><institution-id institution-id-type="ISNI">0000 0000 8970 9163</institution-id><institution>Instituto de Investigacion Sanitaria &#x02018;Hospital la Paz&#x02019; (IdIPaz), </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff108"><label>108</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01cby8j38</institution-id><institution-id institution-id-type="GRID">grid.5515.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 1957 8126</institution-id><institution>Universidad Aut&#x000f3;noma de Madrid, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff109"><label>109</label>Fundaci&#x000f3; Doc&#x000e8;ncia i Recerca M&#x000fa;tuaTerrassa, Terrassa, Barcelona, Spain </aff><aff id="Aff110"><label>110</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/011335j04</institution-id><institution-id institution-id-type="GRID">grid.414875.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1794 4956</institution-id><institution>Memory Disorders Unit, Department of Neurology, Hospital Universitari Mutua de Terrassa, </institution><institution>Terrassa, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff111"><label>111</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/021018s57</institution-id><institution-id institution-id-type="GRID">grid.5841.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0247</institution-id><institution>Alzheimer&#x02019;s Disease and Other Cognitive Disorders Unit, Service of Neurology, Hospital Cl&#x000ed;nic of Barcelona, Institut d&#x02019;Investigacions Biom&#x000e8;diques August Pi i Sunyer, </institution><institution>University of Barcelona, </institution></institution-wrap>Barcelona, Spain </aff><aff id="Aff112"><label>112</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03v85ar63</institution-id><institution-id institution-id-type="GRID">grid.411052.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 2176 9028</institution-id><institution>Laboratorio de Gen&#x000e9;tica, Hospital Universitario Central de Asturias, </institution></institution-wrap>Oviedo, Spain </aff><aff id="Aff113"><label>113</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05xzb7x97</institution-id><institution-id institution-id-type="GRID">grid.511562.4</institution-id><institution>Instituto de Investigaci&#x000f3;n Sanitaria del Principado de Asturias (ISPA), </institution></institution-wrap>Oviedo, Spain </aff><aff id="Aff114"><label>114</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/031zwx660</institution-id><institution-id institution-id-type="GRID">grid.414816.e</institution-id><institution-id institution-id-type="ISNI">0000 0004 1773 7922</institution-id><institution>Unidad de Trastornos del Movimiento, Servicio de Neurolog&#x000ed;a y Neurofisiolog&#x000ed;a, Instituto de Biomedicina de Sevilla (IBiS), </institution><institution>Hospital Universitario Virgen del Roc&#x000ed;o/CSIC/Universidad de Sevilla, </institution></institution-wrap>Seville, Spain </aff><aff id="Aff115"><label>115</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04cxs7048</institution-id><institution-id institution-id-type="GRID">grid.412800.f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1768 1690</institution-id><institution>Unidad Cl&#x000ed;nica de Enfermedades Infecciosas y Microbiolog&#x000ed;a, Hospital Universitario de Valme, </institution></institution-wrap>Sevilla, Spain </aff><aff id="Aff116"><label>116</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/036b2ww28</institution-id><institution-id institution-id-type="GRID">grid.10215.37</institution-id><institution-id institution-id-type="ISNI">0000 0001 2298 7828</institution-id><institution>Depatamento de Especialidades Quir&#x000fa;rgicas, </institution><institution>Bioqu&#x000ed;mica e Inmunolog&#x000ed;a, Facultad de Medicina, Universidad de M&#x000e1;laga, </institution></institution-wrap>M&#x000e1;laga, Spain </aff><aff id="Aff117"><label>117</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/006gamx40</institution-id><institution-id institution-id-type="GRID">grid.490181.5</institution-id><institution>Unitat Trastorns Cognitius, </institution><institution>Hospital Universitari Santa Maria de Lleida, </institution></institution-wrap>Lleida, Spain </aff><aff id="Aff118"><label>118</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03mfyme49</institution-id><institution-id institution-id-type="GRID">grid.420395.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 0425 020X</institution-id><institution>Institut de Recerca Biomedica de Lleida (IRBLLeida), </institution></institution-wrap>Lleida, Spain </aff><aff id="Aff119"><label>119</label>Alzheimer Research Center &#x00026; Memory Clinic, Andalusian Institute for Neuroscience, M&#x000e1;laga, Spain </aff><aff id="Aff120"><label>120</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01w4yqf75</institution-id><institution-id institution-id-type="GRID">grid.411325.0</institution-id><institution-id institution-id-type="ISNI">0000 0001 0627 4262</institution-id><institution>Neurology Service, </institution><institution>Marqu&#x000e9;s de Valdecilla University Hospital (University of Cantabria and IDIVAL), </institution></institution-wrap>Santander, Spain </aff><aff id="Aff121"><label>121</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00cyydd11</institution-id><institution-id institution-id-type="GRID">grid.9668.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0726 2490</institution-id><institution>Institute of Clinical Medicine&#x02014;Neurology, </institution><institution>University of Eastern Finland, </institution></institution-wrap>Kuopio, Finland </aff><aff id="Aff122"><label>122</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01c27hj86</institution-id><institution-id institution-id-type="GRID">grid.9983.b</institution-id><institution-id institution-id-type="ISNI">0000 0001 2181 4263</institution-id><institution>Faculty of Medicine, </institution><institution>University of Lisbon, </institution></institution-wrap>Lisbon, Portugal </aff><aff id="Aff123"><label>123</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01n9zy652</institution-id><institution-id institution-id-type="GRID">grid.410563.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0621 0092</institution-id><institution>Clinic of Neurology, UH &#x0201c;Alexandrovska&#x0201d;, </institution><institution>Medical University&#x02014;Sofia, </institution></institution-wrap>Sofia, Bulgaria </aff><aff id="Aff124"><label>124</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/024d6js02</institution-id><institution-id institution-id-type="GRID">grid.4491.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 116X</institution-id><institution>Memory Clinic, Department of Neurology, Charles University, </institution><institution>Second Faculty of Medicine and Motol University Hospital, </institution></institution-wrap>Praha, Czech Republic </aff><aff id="Aff125"><label>125</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03mchdq19</institution-id><institution-id institution-id-type="GRID">grid.475435.4</institution-id><institution>Department of Clinical Biochemistry, </institution><institution>Copenhagen University Hospital&#x02014;Rigshospitalet, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff126"><label>126</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00q6h8f30</institution-id><institution-id institution-id-type="GRID">grid.16872.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0435 165X</institution-id><institution>Department of Clinical Genetics, </institution><institution>VU University Medical Centre, </institution></institution-wrap>Amsterdam, The Netherlands </aff><aff id="Aff127"><label>127</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/018906e22</institution-id><institution-id institution-id-type="GRID">grid.5645.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 0459 992X</institution-id><institution>Department of Neurology, </institution><institution>Erasmus MC, </institution></institution-wrap>Rotterdam, The Netherlands </aff><aff id="Aff128"><label>128</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02jz4aj89</institution-id><institution-id institution-id-type="GRID">grid.5012.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0481 6099</institution-id><institution>Maastricht University, Department of Psychiatry &#x00026; Neuropsychologie, </institution><institution>Alzheimer Center Limburg, </institution></institution-wrap>Maastricht, The Netherlands </aff><aff id="Aff129"><label>129</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00m8d6786</institution-id><institution-id institution-id-type="GRID">grid.24381.3c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9241 5705</institution-id><institution>Unit for Hereditary Dementias, Theme Aging, </institution><institution>Karolinska University Hospital-Solna, </institution></institution-wrap>171 64, Stockholm, Sweden </aff><aff id="Aff130"><label>130</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/056d84691</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Aging Research Center, Department of Neurobiology, Care Sciences and Society, </institution><institution>Karolinska Institutet and Stockholm University, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff131"><label>131</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/048a87296</institution-id><institution-id institution-id-type="GRID">grid.8993.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 9457</institution-id><institution>Department of Public Health and Caring Sciences/Geriatrics, </institution><institution>Uppsala University, </institution></institution-wrap>Uppsala, Sweden </aff><aff id="Aff132"><label>132</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/004yvsb77</institution-id><institution-id institution-id-type="GRID">grid.418135.a</institution-id><institution-id institution-id-type="ISNI">0000 0004 0641 3404</institution-id><institution>Universit&#x000e9; Paris-Saclay, CEA, </institution><institution>Centre National de Recherche en G&#x000e9;nomique Humaine, </institution></institution-wrap>91057 Evry, France </aff><aff id="Aff133"><label>133</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03nhjew95</institution-id><institution-id institution-id-type="GRID">grid.10400.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2108 3034</institution-id><institution>Univ Rouen Normandie, Normandie Univ, Inserm U1245 and CHU Rouen, </institution><institution>Department of Genetics and CNRMAJ, </institution></institution-wrap>F-76000 Rouen, France </aff><aff id="Aff134"><label>134</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/057qpr032</institution-id><institution-id institution-id-type="GRID">grid.412041.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 639X</institution-id><institution>Inserm, Bordeaux Population Health Research Center, UMR 1219, Univ. Bordeaux, ISPED, CIC 1401-EC, </institution><institution>Univ. Bordeaux, </institution></institution-wrap>Bordeaux, France </aff><aff id="Aff135"><label>135</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01hq89f96</institution-id><institution-id institution-id-type="GRID">grid.42399.35</institution-id><institution-id institution-id-type="ISNI">0000 0004 0593 7118</institution-id><institution>CHU de Bordeaux, </institution><institution>Pole Sant&#x000e9; Publique, </institution></institution-wrap>Bordeaux, France </aff><aff id="Aff136"><label>136</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02kzqn938</institution-id><institution-id institution-id-type="GRID">grid.503422.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2242 6780</institution-id><institution>Univ. Lille, Inserm 1171, </institution><institution>CHU Clinical and Research Memory Research Centre (CMRR) of Distalz, </institution></institution-wrap>Lille, France </aff><aff id="Aff137"><label>137</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01m11mf96</institution-id><institution-id institution-id-type="GRID">grid.413802.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 0011 8533</institution-id><institution>Universit&#x000e9; de Paris, EA 4468, APHP, </institution><institution>H&#x000f4;pital Broca, </institution></institution-wrap>Paris, France </aff><aff id="Aff138"><label>138</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00xzzba89</institution-id><institution-id institution-id-type="GRID">grid.508062.9</institution-id><institution-id institution-id-type="ISNI">0000 0004 8511 8605</institution-id><institution>University Bordeaux, Inserm, </institution><institution>Bordeaux Population Health Research Center, </institution></institution-wrap>Bordeaux, France </aff><aff id="Aff139"><label>139</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/057qpr032</institution-id><institution-id institution-id-type="GRID">grid.412041.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 2106 639X</institution-id><institution>Department of Neurology, </institution><institution>Bordeaux University Hospital, </institution></institution-wrap>Bordeaux, France </aff><aff id="Aff140"><label>140</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02crff812</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution>Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry Zurich, </institution><institution>University of Zurich, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff141"><label>141</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02crff812</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution>Neuroscience Center Zurich, </institution><institution>University of Zurich and ETH Zurich, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff142"><label>142</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02crff812</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution>Zurich Center for Integrative Human Physiology, </institution><institution>University of Zurich, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff143"><label>143</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05a353079</institution-id><institution-id institution-id-type="GRID">grid.8515.9</institution-id><institution-id institution-id-type="ISNI">0000 0001 0423 4662</institution-id><institution>Old Age Psychiatry, Department of Psychiatry, </institution><institution>Lausanne University Hospital, </institution></institution-wrap>Lausanne, Switzerland </aff><aff id="Aff144"><label>144</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01462r250</institution-id><institution-id institution-id-type="GRID">grid.412004.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 0478 9977</institution-id><institution>Department of Geriatric Psychiatry, </institution><institution>University Hospital of Psychiatry Z&#x000fc;rich, </institution></institution-wrap>Z&#x000fc;rich, Switzerland </aff><aff id="Aff145"><label>145</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02crff812</institution-id><institution-id institution-id-type="GRID">grid.7400.3</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0650</institution-id><institution>Institute for Regenerative Medicine, </institution><institution>University of Z&#x000fc;rich, </institution></institution-wrap>Zurich, Switzerland </aff><aff id="Aff146"><label>146</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02davtb12</institution-id><institution-id institution-id-type="GRID">grid.419422.8</institution-id><institution>Molecular Markers Laboratory, </institution><institution>IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, </institution></institution-wrap>Brescia, 25125 Italy </aff><aff id="Aff147"><label>147</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/016zn0y21</institution-id><institution-id institution-id-type="GRID">grid.414818.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 8749</institution-id><institution>Neurodegenerative Diseases Unit, Fondazione IRCCS Ca&#x02019; Granda, </institution><institution>Ospedale Policlinico, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff148"><label>148</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00wjc7c48</institution-id><institution-id institution-id-type="GRID">grid.4708.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2822</institution-id><institution>Department of Biomedical, Surgical and Dental Sciences, </institution><institution>University of Milan, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff149"><label>149</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00wjc7c48</institution-id><institution-id institution-id-type="GRID">grid.4708.b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2822</institution-id><institution>Department of Clinical Sciences and Community Health, </institution><institution>University of Milan, </institution></institution-wrap>20122 Milan, Italy </aff><aff id="Aff150"><label>150</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/016zn0y21</institution-id><institution-id institution-id-type="GRID">grid.414818.0</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 8749</institution-id><institution>Geriatric Unit, </institution><institution>Fondazione IRCCS Ca&#x02019; Granda Ospedale Maggiore Policlinico, </institution></institution-wrap>20122 Milan, Italy </aff><aff id="Aff151"><label>151</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00x27da85</institution-id><institution-id institution-id-type="GRID">grid.9027.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3630</institution-id><institution>Institute of Gerontology and Geriatrics, Department of Medicine and Surgery, </institution><institution>University of Perugia, </institution></institution-wrap>Perugia, Italy </aff><aff id="Aff152"><label>152</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/056d84691</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution>Division of Clinical Geriatrics, Department of Neurobiology, Care Sciences and Society, </institution><institution>Karolinska Institutet, </institution></institution-wrap>Stockholm, Sweden </aff><aff id="Aff153"><label>153</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/027ynra39</institution-id><institution-id institution-id-type="GRID">grid.7644.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 0120 3326</institution-id><institution>Interdisciplinary Department of Medicine, Geriatric Medicine and Memory Unit, </institution><institution>University of Bari &#x0201c;A. Moro&#x0201d;, </institution></institution-wrap>Bari, Italy </aff><aff id="Aff154"><label>154</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00x27da85</institution-id><institution-id institution-id-type="GRID">grid.9027.c</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 3630</institution-id><institution>Centre for Memory Disturbances, Lab of Clinical Neurochemistry, Section of Neurology, </institution><institution>University of Perugia, </institution></institution-wrap>Perugia, Italy </aff><aff id="Aff155"><label>155</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/003109y17</institution-id><institution-id institution-id-type="GRID">grid.7763.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1755 3242</institution-id><institution>Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, </institution><institution>University of Cagliari, </institution></institution-wrap>Cagliari, Italy </aff><aff id="Aff156"><label>156</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01ynf4891</institution-id><institution-id institution-id-type="GRID">grid.7563.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 2174 1754</institution-id><institution>Neurology Unit, &#x0201c;San Gerardo&#x0201d; Hospital, </institution><institution>Monza and University of Milano-Bicocca, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff157"><label>157</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02q2d2610</institution-id><institution-id institution-id-type="GRID">grid.7637.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 1846</institution-id><institution>Department of Clinical and Experimental Sciences, </institution><institution>University of Brescia, </institution></institution-wrap>Brescia, Italy </aff><aff id="Aff158"><label>158</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/015rhss58</institution-id><institution-id institution-id-type="GRID">grid.412725.7</institution-id><institution>Cognitive and Behavioural Neurology, Department of Continuity of Care and Frailty, </institution><institution>ASST Spedali Civili Brescia, </institution></institution-wrap>Brescia, Italy </aff><aff id="Aff159"><label>159</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04jr1s763</institution-id><institution-id institution-id-type="GRID">grid.8404.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 2304</institution-id><institution>Department of Neuroscience, Psychology, </institution><institution>Drug Research and Child Health University of Florence, </institution></institution-wrap>Florence, Italy </aff><aff id="Aff160"><label>160</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02e3ssq97</institution-id><institution-id institution-id-type="GRID">grid.418563.d</institution-id><institution-id institution-id-type="ISNI">0000 0001 1090 9021</institution-id><institution>IRCCS Fondazione Don Carlo Gnocchi, </institution></institution-wrap>Florence, Italy </aff><aff id="Aff161"><label>161</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05xrcj819</institution-id><institution-id institution-id-type="GRID">grid.144189.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1756 8209</institution-id><institution>Department of Medicine and Surgery, Unit of Neurology, </institution><institution>University-Hospital of Parma, </institution></institution-wrap>Parma, Italy </aff><aff id="Aff162"><label>162</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/04fvmv716</institution-id><institution-id institution-id-type="GRID">grid.417011.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1769 6825</institution-id><institution>Department of Hematology and Stem Cell Transplant, </institution><institution>Vito Fazzi Hospital, </institution></institution-wrap>Lecce, Italy </aff><aff id="Aff163"><label>163</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/048tbm396</institution-id><institution-id institution-id-type="GRID">grid.7605.4</institution-id><institution-id institution-id-type="ISNI">0000 0001 2336 6580</institution-id><institution>Department of Neuroscience &#x0201c;Rita Levi Montalcini&#x0201d;, </institution><institution>University of Torino, </institution></institution-wrap>Torino, Italy </aff><aff id="Aff164"><label>164</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03h7r5v07</institution-id><institution-id institution-id-type="GRID">grid.8142.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 3192</institution-id><institution>Department of Neuroscience, </institution><institution>Universit&#x000e0; Cattolica del Sacro Cuore, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff165"><label>165</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rg70c39</institution-id><institution-id institution-id-type="GRID">grid.411075.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 1760 4193</institution-id><institution>Neurology Unit, </institution><institution>IRCCS Fondazione Policlinico Universitario A. Gemelli, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff166"><label>166</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05rcxtd95</institution-id><institution-id institution-id-type="GRID">grid.417778.a</institution-id><institution-id institution-id-type="ISNI">0000 0001 0692 3437</institution-id><institution>Laboratory of Experimental Neuropsychobiology, </institution><institution>IRCCS Santa Lucia Foundation, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff167"><label>167</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03h7r5v07</institution-id><institution-id institution-id-type="GRID">grid.8142.f</institution-id><institution-id institution-id-type="ISNI">0000 0001 0941 3192</institution-id><institution>Institute of Neurology, </institution><institution>Catholic University of the Sacred Heart, </institution></institution-wrap>Rome, Italy </aff><aff id="Aff168"><label>168</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05rbx8m02</institution-id><institution-id institution-id-type="GRID">grid.417894.7</institution-id><institution-id institution-id-type="ISNI">0000 0001 0707 5492</institution-id><institution>Fondazione IRCCS Istituto Neurologico Carlo Besta, </institution></institution-wrap>Milan, Italy </aff><aff id="Aff169"><label>169</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rcxh774</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Department of Psychiatry and Psychotherapy, Faculty of Medicine and University Hospital Cologne, </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff170"><label>170</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rcxh774</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Cluster of Excellence Cellular Stress Responses in Aging-associated Diseases (CECAD), </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff171"><label>171</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0524sp257</institution-id><institution-id institution-id-type="GRID">grid.5337.2</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7603</institution-id><institution>Translational Health Sciences, Bristol Medical School, </institution><institution>University of Bristol, </institution></institution-wrap>Bristol, UK </aff><aff id="Aff172"><label>172</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/035b05819</institution-id><institution-id institution-id-type="GRID">grid.5254.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0674 042X</institution-id><institution>Department of Clinical Medicine, </institution><institution>University of Copenhagen, </institution></institution-wrap>Copenhagen, Denmark </aff><aff id="Aff173"><label>173</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/029cgt552</institution-id><institution-id institution-id-type="GRID">grid.12574.35</institution-id><institution-id institution-id-type="ISNI">0000000122959819</institution-id><institution>Laboratory of Genetics, Immunology and Human Pathology, Faculty of Science of Tunis, </institution><institution>University of Tunis El Manar, </institution></institution-wrap>2092 Tunis, Tunisia </aff><aff id="Aff174"><label>174</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00ca2c886</institution-id><institution-id institution-id-type="GRID">grid.413448.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 9314 1427</institution-id><institution>Alzheimer&#x02019;s Centre Reina Sofia-CIEN Foundation-ISCIII, </institution></institution-wrap>Madrid, Spain </aff><aff id="Aff175"><label>175</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/042xt5161</institution-id><institution-id institution-id-type="GRID">grid.231844.8</institution-id><institution-id institution-id-type="ISNI">0000 0004 0474 0428</institution-id><institution>Krembil Brain Institute, </institution><institution>University Health Network, </institution></institution-wrap>Toronto, ON Canada </aff><aff id="Aff176"><label>176</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03dbr7087</institution-id><institution-id institution-id-type="GRID">grid.17063.33</institution-id><institution-id institution-id-type="ISNI">0000 0001 2157 2938</institution-id><institution>Tanz Centre for Research in Neurodegenerative Diseases, Departments of Medicine and Laboratory Medicine &#x00026; Pathobiology, </institution><institution>University of Toronto, </institution></institution-wrap>Toronto, ON Canada </aff><aff id="Aff177"><label>177</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/051fd9666</institution-id><institution-id institution-id-type="GRID">grid.67105.35</institution-id><institution-id institution-id-type="ISNI">0000 0001 2164 3847</institution-id><institution>Department of Population and Quantitative Health Sciences and Cleveland Institute for Computational Biology, </institution><institution>Case Western Reserve University, </institution></institution-wrap>Cleveland, OH USA </aff><aff id="Aff178"><label>178</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Biostatistics, </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff179"><label>179</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Epidemiology, </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff180"><label>180</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Medicine (Biomedical Genetics), </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff181"><label>181</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Ophthalmology, </institution><institution>Boston University, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff182"><label>182</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00hj8s172</institution-id><institution-id institution-id-type="GRID">grid.21729.3f</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8729</institution-id><institution>Gertrude H. Sergievsky Center, </institution><institution>Columbia University, </institution></institution-wrap>New York, NY USA </aff><aff id="Aff183"><label>183</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00b30xv10</institution-id><institution-id institution-id-type="GRID">grid.25879.31</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8972</institution-id><institution>Department of Pathology and Laboratory Medicine, </institution><institution>University of Pennsylvania Perelman School of Medicine, </institution></institution-wrap>Philadelphia, PA USA </aff><aff id="Aff184"><label>184</label>Glenn Biggs Institute for Alzheimer&#x02019;s and Neurodegenerative Diseases, San Antonio, TX USA </aff><aff id="Aff185"><label>185</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Boston University and the NHLBI&#x02019;s Framingham Heart Study, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff186"><label>186</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05qwgg493</institution-id><institution-id institution-id-type="GRID">grid.189504.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7558</institution-id><institution>Department of Neurology, </institution><institution>Boston University School of Medicine, </institution></institution-wrap>Boston, MA USA </aff><aff id="Aff187"><label>187</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03kk7td41</institution-id><institution-id institution-id-type="GRID">grid.5600.3</institution-id><institution-id institution-id-type="ISNI">0000 0001 0807 5670</institution-id><institution>UK Dementia Research Institute, </institution><institution>Cardiff University, </institution></institution-wrap>Cardiff, UK </aff><aff id="Aff188"><label>188</label>Department of Psychiatry &#x00026; Glenn Biggs Institute for Alzheimer&#x02019;s and Neurodegenerative Diseases, San Antonio, TX USA </aff><aff id="Aff189"><label>189</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00rcxh774</institution-id><institution-id institution-id-type="GRID">grid.6190.e</institution-id><institution-id institution-id-type="ISNI">0000 0000 8580 3777</institution-id><institution>Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Disease (CECAD), </institution><institution>University of Cologne, </institution></institution-wrap>Cologne, Germany </aff><aff id="Aff190"><label>190</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>Dr. John T. Macdonald Foundation Department of Human Genetics, </institution><institution>University of Miami, </institution></institution-wrap>Miami, FL USA </aff><aff id="Aff191"><label>191</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00j9c2840</institution-id><institution-id institution-id-type="GRID">grid.55325.34</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 8485</institution-id><institution>NORMENT Centre, Division of Mental Health and Addiction, </institution><institution>Oslo University Hospital, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff192"><label>192</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xtthb56</institution-id><institution-id institution-id-type="GRID">grid.5510.1</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8921</institution-id><institution>Institute of Clinical Medicine, </institution><institution>University of Oslo, </institution></institution-wrap>Oslo, Norway </aff><aff id="Aff193"><label>193</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01pxwe438</institution-id><institution-id institution-id-type="GRID">grid.14709.3b</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8649</institution-id><institution>Department of Epidemiology, Biostatistics and Occupational Health, </institution><institution>McGill University, </institution></institution-wrap>Montreal, QC Canada </aff><aff id="Aff194"><label>194</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/02dgjyy92</institution-id><institution-id institution-id-type="GRID">grid.26790.3a</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 8606</institution-id><institution>University of Miami Miller School of Medicine, </institution></institution-wrap>Miami, FL USA </aff></contrib-group><pub-date pub-type="epub"><day>4</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>4</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>30</volume><issue>6</issue><fpage>2335</fpage><lpage>2346</lpage><history><date date-type="received"><day>18</day><month>6</month><year>2024</year></date><date date-type="rev-recd"><day>5</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>7</day><month>11</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer&#x02019;s Disease (AD). To address this and better characterize the genetic landscape of AD, we performed an in-depth X-Chromosome-Wide Association Study (XWAS) in 115,841 AD cases or AD proxy cases, including 52,214 clinically-diagnosed AD cases, and 613,671 controls. We considered three approaches to account for the different X-chromosome inactivation (XCI) states in females, i.e. random XCI, skewed XCI, and escape XCI. We did not detect any genome-wide significant signals (P&#x02009;&#x02264;&#x02009;5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;</sup><sup>8</sup>) but identified seven X-chromosome-wide significant loci (P&#x02009;&#x02264;&#x02009;1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;</sup><sup>6</sup>). The index variants were common for the Xp22.32, <italic>FRMPD4, DMD</italic> and Xq25 loci, and rare for the <italic>WNK3</italic>, <italic>PJA1</italic>, and <italic>DACH2</italic> loci. Overall, this well-powered XWAS found no genetic risk factors for AD on the non-pseudoautosomal region of the X-chromosome, but it identified suggestive signals warranting further investigations.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Genetics</kwd><kwd>Diseases</kwd><kwd>Neuroscience</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Alzheimer&#x02019;s disease (AD) is a progressive neurodegenerative disease and the most common cause of dementia among the elderly. AD is caused by a combination of modifiable and non-modifiable risk factors, including genetics. Currently, more than 80 genetic loci are associated with AD risk, highlighting several underlying biological mechanisms for AD, including APP metabolism, Tau-mediated toxicity, lipid metabolism or immune-related processes [<xref ref-type="bibr" rid="CR1">1</xref>&#x02013;<xref ref-type="bibr" rid="CR6">6</xref>]. Greater understanding of the genetics of AD is essential to improve the characterization of the pathophysiological processes involved in the disease. However, although the genetic landscape of AD has been extensively studied on the autosomes, little is known about the association of the X-chromosome gene variants with AD risk. To date, large-scale genome-wide association studies (GWAS) did not include the X-chromosome due to the need of specific analyses to account for its features.</p><p id="Par3">While women carry two copies of the X-chromosome, men are hemizygous, meaning they have one X and one Y chromosome. To maintain balance around allelic dosage between the sexes, X-chromosome inactivation (XCI) occurs in females. This process is where one X chromosome is transcriptionally silenced during female development [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. The choice of the silenced copy is most often random (random XCI or r-XCI), but inactivation can also be skewed toward a specific copy (skewed XCI or s-XCI). Such XCI &#x02018;skewness&#x02019; can be subsequently acquired during life and has been described to increase with age in adults [<xref ref-type="bibr" rid="CR9">9</xref>&#x02013;<xref ref-type="bibr" rid="CR12">12</xref>]. Importantly, up to one&#x02010;third of X&#x02010;chromosome genes &#x02018;escape&#x02019; inactivation and are expressed from both X&#x02010;chromosomes in female cells (escape XCI or e-XCI). However, these tend to be expressed less from the inactive X-chromosome. Notably, all the genes in the pseudoautosomal region (PAR) 1 of the X-chromosome have Y-chromosome homologues and escape inactivation. Additionally, some genes variably escape inactivation: their expression from the inactive X-chromosome differs between individuals or between cells and tissues within an individual [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. The inactivation process and the distinction between the PAR and non-PAR regions are thus important considerations when performing an X-chromosome-wide association study (XWAS). For all these reasons, the X-chromosome needs to be treated separately from the autosomes in the quality control (QC), the imputation process and the analysis [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], and has usually been excluded from GWAS, including for the large-scale AD ones. Yet, the X-chromosome represents about 5% of the genome in terms of size and number of genes (UCSC Genome Browser, <ext-link ext-link-type="uri" xlink:href="https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&#x00026;chromInfoPage=">https://genome.ucsc.edu/cgi-bin/hgTracks?db=hg38&#x00026;chromInfoPage=</ext-link>), and thus the study of AD genetics remains incomplete.</p><p id="Par4">Several X-chromosome genes have been associated with brain imaging phenotypes [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. Furthermore, the X-chromosome carries, disproportionately for the whole genome, more than 15% of the known genes related to intellectual disabilities [<xref ref-type="bibr" rid="CR18">18</xref>]. While genes related to intellectual disabilities are considered to modulate early neurodevelopmental stages well before neurodegenerative processes start, they might impact on the development of cognitive abilities and, potentially, on the establishment of cognitive reserve and brain resilience [<xref ref-type="bibr" rid="CR19">19</xref>]. Additionally, XCI escape or skewness might contribute to observed sex differences reported in AD [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. Women have a higher risk of developing dementia than men: in the 65&#x02013;69 and 85&#x02013;89 age groups, the prevalence is 1.5% and 24.9% respectively for women, compared with 1.1% and 16.3% for men [<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]. However, conclusions regarding differences of incidence across men and women are more mixed [<xref ref-type="bibr" rid="CR23">23</xref>&#x02013;<xref ref-type="bibr" rid="CR27">27</xref>]. Indeed, the sex difference in prevalence can be largely explained by a greater longevity of women, although other factors may also be involved, such as a selective survival bias in men, socio-environmental factors, or different AD-related biological mechanisms between sexes [<xref ref-type="bibr" rid="CR28">28</xref>]. For example, women have a greater tau burden than men [<xref ref-type="bibr" rid="CR29">29</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>] and the impact of <italic>APOE</italic> variants on the disease risk or on Tau concentration differs between males and females [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. Additionally, in the general population, women have better memory performance [<xref ref-type="bibr" rid="CR39">39</xref>&#x02013;<xref ref-type="bibr" rid="CR43">43</xref>]; some studies reported a faster decline of the global cognition in women but results were mixed in the literature [<xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]. However, among people with mild cognitive impairment, cognitive decline is reportedly faster in women than in men [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Additionally, women live longer with AD compared to men [<xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR48">48</xref>]. Consistent with this, in AD mouse models, having two X-chromosomes was associated with reduced mortality [<xref ref-type="bibr" rid="CR47">47</xref>]. This advantage conferred by a second X-chromosome could partly relate to the <italic>KDM6A</italic> gene, which escapes inactivation. A variant of the human version of this gene was associated with an increase in this gene&#x02019;s expression in the brain, and with less cognitive decline in aging and preclinical AD [<xref ref-type="bibr" rid="CR47">47</xref>]. Finally, in humans, expression/level of other X-linked genes or proteins are reportedly associated with cognitive change or tau pathology in a sex-specific manner [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par5">To investigate the impact of X-chromosome genetic variants on AD risk, we conducted an in-depth XWAS on 115,841 AD cases or AD proxy cases and 613,671 controls from the IGAP (International Genomics of Alzheimer&#x02019;s Project), EADB (European Alzheimer &#x00026; Dementia Biobank), UK Biobank (UKB) and FinnGen studies (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S1</xref>). We considered three approaches to account for the different inactivation states in females, i.e. r-XCI, s-XCI, and e-XCI [<xref ref-type="bibr" rid="CR15">15</xref>]. In the r-XCI model, males were considered as homozygous females, while they were coded hemizygous in the e-XCI model. In the s-XCI model, a dominance effect was added to the r-XCI model to account for non-random inactivation in females.</p></sec><sec id="Sec2"><title>Method</title><sec id="Sec3"><title>Samples</title><p id="Par6">The XWAS is based on 115,841 AD or AD-proxy cases (58% females) and 613,671 controls (55% females) of European ancestry from 35 case-control studies, 2 family studies (LOAD and FHS), and 2 biobanks (UKB and FinnGen) (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref> and Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S1</xref>). 55,868 of the 115,841 cases were AD-proxy cases from the UKB. Females were considered as AD-proxy cases if they indicated having at least one parent with dementia [<xref ref-type="bibr" rid="CR51">51</xref>]. For males, only the mother&#x02019;s status was used to define the proxy status (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>). In a sensitivity analysis including only the diagnosed AD cases, a total of 63,838 AD-cases (59% females) and 806,335 controls (55% females) was considered (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S1</xref>).</p><p id="Par7">Additionally, we also analyzed levels of the two cerebro-spinal fluid biomarkers A&#x003b2;42 and phosphorylated tau (pTau) in 5522 and 5415 EADB-core samples, respectively [<xref ref-type="bibr" rid="CR52">52</xref>] (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S2</xref>). We also considered 2661 samples with cognitive impairment from three population-based longitudinal studies: AgeCode [<xref ref-type="bibr" rid="CR53">53</xref>], SNAC-K [<xref ref-type="bibr" rid="CR54">54</xref>] (both included in EADB-core) and 3C [<xref ref-type="bibr" rid="CR55">55</xref>] (included in EADI) (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S3</xref>). Definitions of cognitive impairment are described in the respective references. These individuals are at increased risk for dementia, but their speed of progression is heterogeneous. For each sample, a Mini-Mental State Examination (MMSE) score was obtained at baseline and in 1 to 5 follow-up sessions.</p><p id="Par8">In addition to the classical autosomal QC, an X-chromosome specific QC was performed prior to imputation for each study (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref> and Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S4</xref>). We did not analyze the PAR regions due to a lack of variants on most genotyping chips. Related individuals were excluded from UKB samples but were kept in FinnGen, where related individuals&#x02019; exclusion accounts for about 40% of the sample size [<xref ref-type="bibr" rid="CR56">56</xref>].</p><p id="Par9">Thirty-four studies were imputed with the TOPMed [<xref ref-type="bibr" rid="CR57">57</xref>] panel (N&#x02009;=&#x02009;112,690) and three studies were imputed with the 1000 Genomes [<xref ref-type="bibr" rid="CR58">58</xref>] panel (March 2012) (FHS, CHS and RS, N&#x02009;=&#x02009;10,102, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S4</xref>). The FinnGen was imputed with a Finnish reference panel and the UKB with a combination of 1000 Genomes, HRC [<xref ref-type="bibr" rid="CR59">59</xref>] and UK10K [<xref ref-type="bibr" rid="CR60">60</xref>] panels.</p></sec><sec id="Sec4"><title>Main analyses</title><sec id="Sec5"><title>Association tests</title><p id="Par10">Since random X-chromosome inactivation is the most frequent case, we considered the r-XCI approach for our main analysis and the s-XCI and e-XCI approaches for secondary analyses. The approaches are described briefly below, while additional details are provided in the&#x000a0;<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>. An overview of the study design is represented in Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>. For all the models, the analyses were adjusted on the principal components (PCs) and/or the genotyping center if necessary (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S4</xref>). Dosage or genotype probabilities were used for all studies but FinnGen, where best guessed genotypes were considered (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><title>Study design of the AD-XWAS.</title><p><bold>a</bold> Main analyses and <bold>b</bold> sensitivity analyses. Box colors indicate the approach: purple, green, orange and blue represent r-XCI, s-XCI, e-XCI and sex-stratified approaches, respectively. Boxes circled in red are the main r-XCI, s-XCI and e-XCI analyses. *Fixed effect meta-analysis with an inverse-variance weighted approach as implemented in METAL [<xref ref-type="bibr" rid="CR64">64</xref>]. **Sex-stratified models were adjusted on 1) principal components (PCs) and/or the genotyping center; 2) PCs, center and age; 3) PCs, center, age and <italic>APOE</italic>.</p></caption><graphic xlink:href="41380_2024_2838_Fig1_HTML" id="d33e3695"/></fig></p><sec id="FPar1"><title>r-XCI approach</title><p id="Par11">The r-XCI approach is equivalent to an additive genetic model, where males are considered as homozygous females. Males&#x02019; and females&#x02019; genotypes were thus coded: genotype (G)&#x02009;=&#x02009;{0, 2} and G = {0, 1, 2} respectively. The association test was performed for each study in men and women jointly using an additive logistic regression model for case-control studies, a generalized estimating equation (GEE) model for family studies and a logistic mixed model for biobanks. To account for differences in genotypic variance between sexes, we considered a robust estimate of the variance (or Huber-White Sandwich estimator, accounting for heterogeneity of variance within a regression model, <xref rid="MOESM1" ref-type="media">Supplementary Material</xref>) for case-control studies [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>] and an adjustment on sex for family studies and biobanks (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S5</xref>). The association test on proxy status in UKB was performed separately for males and females, and a correction factor of 2 was applied to the association statistics (effect sizes and standard errors) of the female-only model (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>) [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR63">63</xref>]. The results were then combined across studies in a fixed effect meta-analysis with an inverse-variance weighted approach with METAL [<xref ref-type="bibr" rid="CR64">64</xref>].</p></sec><sec id="FPar2"><title>e-XCI approach</title><p id="Par12">Under the e-XCI hypothesis, males&#x02019; and females&#x02019; genotypes were coded G = {0, 1} and G = {0, 1, 2} respectively. Variant effects were estimated separately in females and in males, except in FinnGen, where the variant effects were estimated directly in both males and females combined with an adjustment on sex (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S5</xref>). Results were then combined across studies, males and females with a fixed effect meta-analysis, inverse variance weighted approach using METAL. We did not include AD-proxy in the e-XCI meta-analysis. As males and females are related in family studies, only female results from LOAD and FHS were included in the meta-analysis. The sex-stratified models were adjusted on PCs and/or the genotyping center only, except for two ADGC studies (PFIZER and TGEN2) and the CHARGE studies (FHS, RS and CHS), where models were additionally adjusted on age (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S6</xref> and <xref rid="MOESM1" ref-type="media">Supplementary Material</xref>).</p></sec><sec id="FPar3"><title>s-XCI approach</title><p id="Par13">For the s-XCI approach, males&#x02019; and females&#x02019; genotypes were coded G = {0, 2} and G = {0, 1, 2} respectively. A general genotypic model, including both an additive and a dominance variable, was estimated in females from case-control studies to account for non-random inactivation through the dominance variable, which equals 1 in female heterozygotes, and 0 otherwise. The &#x003c7;<sup>2</sup> test of the dominance effect was then added to the &#x003c7;<sup>2</sup> test of the additive effect estimated under r-XCI, which results in a two degree of freedom (df) test of the association of the variant with AD risk including its potential skewedness [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR65">65</xref>] (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S5</xref>). We did not include family studies and biobanks in the s-XCI approach.</p><p id="Par14">While analyses and QC of the results (see below) were performed with the coding scheme described above, odds-ratio and confidence intervals are provided on the real XCI scale, i.e. G = {0, 1} for males and G = {0,&#x000a0;0.5,&#x000a0;1} for females under r-XCI and s-XCI, but G = {0, 1} for males and G&#x000a0;=&#x000a0;{0,&#x000a0;1,&#x000a0;2} for females under e-XCI (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S5</xref>).</p></sec><sec id="FPar4"><title>Sex-stratified analyses</title><p id="Par15">As the XCI mechanism induces variability across females, one might expect stronger effects in males compared to females; we therefore performed an additional sex-stratified analysis and compared the variant effect sizes in males and females. Proxy cases were not included in this analysis. We combined the results across studies in males and females separately with a fixed effect meta-analysis and inverse-variance weighted approach using METAL [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR64">64</xref>]. The variant effect sizes of males and females were then compared with a Wald test (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>).</p></sec></sec><sec id="Sec6"><title>Quality control of the results and definition of associated loci</title><p id="Par16">A QC of the results was carried out for all the studies. We filtered out variants with at least one missing datum (on effect, standard error, or <italic>p</italic>-value), an absolute effect size greater than 5, or an imputation quality less than 0.3. We also filtered out the variants whose effective allele count (product of the imputation quality and the expected minimum minor allele count between the cases and the controls) was less than 5, and less than 10 for LOAD [<xref ref-type="bibr" rid="CR66">66</xref>]. For datasets imputed with 1000&#x02009;G and the UKB, we excluded variants for which the conversion of position or alleles from GRCh37 to GRCh38 was not possible or problematic, and variants with a difference in frequency &#x0003e;0.5 compared with the reference panels TOPMed or 1000&#x02009;G.</p><p id="Par17">After the meta-analysis, we filtered the variants analyzed in less than 40% of AD cases (considering the effective sample size of females UKB-proxy, which is the raw sample size divided by four [<xref ref-type="bibr" rid="CR51">51</xref>]), variants with heterogeneity <italic>p</italic>-value&#x02009;&#x0003c;&#x02009;5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup> and variants where the difference between the maximum frequency and the minimum frequency across studies was higher than 0.4.</p><p id="Par18">Inflation of the test statistics was checked in each study and in the meta-analysis by computing a genomic inflation factor &#x003bb; with the median approach implemented in the GenABEL 1.8-0&#x02009;R package [<xref ref-type="bibr" rid="CR67">67</xref>], on common variants in low LD (r<sup>2</sup>&#x02009;&#x0003c;&#x02009;0.2) (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>). A signal was considered genome-wide or X-chromosome-wide significant in either approach if associated with AD risk with P&#x02009;&#x02264;&#x02009;5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup> or P&#x02009;&#x02264;&#x02009;1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>. This X-chromosome wide threshold is based on R&#x02009;=&#x02009;3.12%, the relative number of tests performed on the X-chromosome (n&#x02009;=&#x02009;888,213, r-XCI approach) versus on the autosomes (n&#x02009;=&#x02009;27,549,394) in the EADB-core study, the largest dataset imputed with the TOPMed reference panel. As the genome-wide threshold of 5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup> corresponds to the Bonferroni correction for one million tests, we computed the corresponding threshold for the X-chromosome as 0.05 / (R*1,000,000)&#x02009;=&#x02009;1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>.</p></sec><sec id="Sec7"><title>Sensitivity analyses</title><p id="Par19">To account for potential results that we may have missed because of false negatives related to proxy cases or biobanks, we performed sensitivity analyses on the whole X-chromosome excluding these samples for the r-XCI approach and excluding biobank samples for the e-XCI approach (in the first place, proxy cases were not included in the e-XCI analysis and samples from biobanks, including proxy cases, were not included in the s-XCI analysis).</p><p id="Par20">Additionally, several sensitivity analyses of the identified signals were performed. As the robust r-XCI model can generate false positives in the case of differences of frequency between males and females, we performed a sensitivity analysis by adjusting it on sex rather than using a robust variance for the r-XCI signals. The results were obtained by meta-analyzing the sex-stratified models for all case-control studies and UKB, and a sex-combined model adjusted on sex for FinnGen, with males coded as homozygous females for all models (family studies were excluded) (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S5</xref>). Sensitivity analyses including an adjustment on age and the number of APOE<italic>&#x003b5;</italic>4 and APOE<italic>&#x003b5;</italic>2 alleles were also performed for all signals. Results were obtained from the meta-analysis of adjusted sex-stratified models with the adequate coding of males and excluding family studies. Finally, a sensitivity analysis was performed using a stricter imputation quality filter (r<sup>2</sup>&#x02009;&#x0003e;&#x02009;0.8).</p></sec></sec><sec id="Sec8"><title>Biomarker and cognitive decline analyses</title><p id="Par21">We tested the association of A&#x003b2;<sub>42</sub> and pTau with the genotypes of each common index variant in the EADB-core samples. The analyses were performed separately in 11 batches from 7 European countries (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S2</xref>). Following the protocol used by Jansen et al. 2022 [<xref ref-type="bibr" rid="CR52">52</xref>], we applied a linear regression of the normalized log-transformed levels of A&#x003b2;42 and pTau, adjusted for sex, age, assay type (if applicable), and ten PCs, using SNPTEST &#x02018;expected&#x02019; method [<xref ref-type="bibr" rid="CR68">68</xref>]. Genotype probabilities were used for all batches. Additionally to the filters on variants with missing datum, variants with minor allele frequency or MAF&#x02009;&#x0003c;&#x02009;1% were filtered out, and for batches with less than 250 samples, variants with MAF&#x02009;&#x0003c;&#x02009;5% were also excluded. We applied this model to both the r-XCI and e-XCI approaches, using a meta-analysis of sex-combined models with an r-XCI coding of the genotypes and a meta-analysis of sex-stratified models with an e-XCI coding of the genotypes, respectively.</p><p id="Par22">Evaluating the link of AD-related X-chromosomal variants with cognitive decline may inform about their contribution to the trajectory of the disease. An association study of cognitive decline was thus performed for the common index variants of the X-chromosome wide significant signals using samples with cognitive impairment from longitudinal studies. Both the r-XCI and e-XCI approaches were considered. The association tests were performed in each study in males and females separately using a linear mixed model. The models tested the association between the normalized MMSE score [<xref ref-type="bibr" rid="CR69">69</xref>] and the index variant dosage. To account for the random effect between the individuals, we included a &#x0201c;Time&#x0201d; variable, representing the time between the baseline and each follow-up session for each individual. Females were coded G = {0,0.5,1} and G = {0,1,2} for the r-XCI and e-XCI approaches, respectively, and males were coded G = {0,1} in both approaches. Each model was adjusted for age at baseline and four PCs. We also performed sex-combined quadratic models -including the squared effect of &#x0201c;Time&#x0201d;- adjusted on sex, for both r-XCI and e-XCI approaches, as sensitivity analyses [<xref ref-type="bibr" rid="CR70">70</xref>]. The sex-combined quadratic models were only computed in 3C and AgeCode (the quadratic models did not converge in SNAC-K due to low sample size). We then meta-analyzed together the results of the male-only and female-only linear models of all three studies, and meta-analyzed together the linear and quadratic effects of the sex-combined quadratic model for both approaches.</p><p id="Par23">The significance threshold used for the A&#x003b2;<sub>42</sub>, pTau and cognitive decline association test is 4.17&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>, which corresponds to the Bonferroni correction for the 4 independent common variants analyzed for 3 phenotypes.</p></sec><sec id="Sec9"><title>Colocalization with brain tissue eQTL and pQTL</title><p id="Par24">We performed a genetic colocalization of our hits with brain tissue pQTL and eQTL (protein and expression Quantitative Trait Loci, respectively) for all protein-coding genes within 500&#x02009;kb of each common index variant, using the &#x0201c;coloc.abf&#x0201d; function from the coloc R-package (version 5.2.3). The brain tissue QTL data were extracted from Wingo et al. 2023 [<xref ref-type="bibr" rid="CR71">71</xref>], GTex (11 brain tissues) and CommonMind; the last two were processed by the eQTL Catalog (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/eqtl/Data_access/">https://www.ebi.ac.uk/eqtl/Data_access/</ext-link>). From the GTex data, we identified 20 genes within 500&#x02009;kb of the common index variants. We performed the colocalization analyses using the results of the r-XCI or e-XCI analysis where each AD association signal was identified (either the meta-analyses including AD-proxy cases, the diagnosed AD cases meta-analysis or the meta-analysis excluding biobanks). A colocalization between a brain tissue eQTL or pQTL of a gene and an AD-association signal was considered significant when PP4&#x02009;&#x0003e;&#x02009;0.75 (posterior probability that both traits are associated and share a single causal variant) [<xref ref-type="bibr" rid="CR2">2</xref>].</p></sec><sec id="Sec10"><title>Differential expression and methylation analyses</title><p id="Par25">To evaluate the biological significance of the genes in the identified loci, we examined differential expression and methylation data in studies comparing AD vs control brains and assessing amyloid plaque burden. We considered 19 genes located at +/- 500&#x02009;kb of the index variants.</p><p id="Par26">To explore differential expression of our associated loci, we analyzed postmortem brain pathology expression data from individuals of European ancestry using RNA-seq data obtained from temporal lobe and pre-frontal cortex (GEO: GSE44772, GSE33000, GSE118553). Logistic regressions were performed in males and females separately and were adjusted on age at death (age at last visit for clinical AD diagnosis), postmortem interval, RNA integrity, <italic>APOE &#x003b5;4</italic> status, and first 3 genomic principal components. A significance threshold of 1.32&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> was considered, corresponding to a Bonferroni correction for 19 genes analyzed in two subgroups, that being 38 tests.</p><p id="Par27">Differential methylation of associated loci was assessed by using the DNA Methylation in Aging and Methylation in AD (MIAMI-AD) database (<underline>miami-ad.org</underline>) [<xref ref-type="bibr" rid="CR72">72</xref>] which collates results from epigenome-wide association studies in aging and AD. Studies in the database meet two main criteria: 1) having more than 100 total subjects and 2) conducting a genome-wide study of more than 100k CpGs. Details of individual studies can be found on the MIAMI-AD website. Here we queried genes within the associated loci for association with AD neuropathology or dementia, in males and females separately, but also in the combined sample. A significance threshold of 4.39&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup> was considered, corresponding to a Bonferroni correction for 19 genes analyzed for 2 phenotypes in 3 subgroups, hence a total 114 tests.</p></sec><sec id="Sec11"><title>X-linked intellectual disability (XLID) enrichment analysis</title><p id="Par28">We also tested the enrichment of AD association signals in XLID genes in each approach. We first performed gene-based analyses for each approach (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>) and then compared the enrichment of AD association signals in the 156 XLID genes included in the gene-based analysis (out of 164 XLID genes [<xref ref-type="bibr" rid="CR18">18</xref>]) with the rest of the X-chromosome genes, using MAGMA v1.08 [<xref ref-type="bibr" rid="CR73">73</xref>].</p></sec></sec><sec id="Sec12" sec-type="results"><title>Results</title><sec id="Sec13"><title>XWAS overview</title><p id="Par29">A total of 666,264, 442,001 and 438,420 variants - including 288,320, 276,902 and 263,169 common variants (MAF&#x02009;&#x02265;&#x02009;1%) - were analyzed in the r-XCI, e-XCI and s-XCI approaches, respectively. We observed a minor deviation from expected <italic>p</italic>-values in the r-XCI and e-XCI models (median genomic inflation factor &#x003bb;&#x02009;=&#x02009;1.074 and 1.087, respectively) and a deflation in the s-XCI model (median &#x003bb;&#x02009;=&#x02009;0.735) (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>, Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>&#x02013;<xref rid="MOESM1" ref-type="media">S3</xref> and Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S7</xref>). We did not identify any genome-wide significant signals (P&#x02009;&#x02264;&#x02009;5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>) in any of the models (Figs.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>&#x02013;<xref rid="Fig4" ref-type="fig">4</xref>). However, five loci exhibited signals that were X-chromosome-wide significant (P&#x02009;&#x02264;&#x02009;1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>) in the r-XCI approach; the index variants were common for the Xp22.32, <italic>FRMPD4</italic> and Xq25 loci, and rare for the <italic>PJA1</italic> and <italic>TMEM187-G6PD/IKBKG</italic> loci (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>). Additionally, a rare variant in the <italic>WNK3</italic> gene was X-chromosome-wide significant in the e-XCI analysis (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>). No X-chromosome-wide significant signal was found in the s-XCI analysis (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). As expected, we observed correlated results between the r-XCI and e-XCI meta-analysis results (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S9</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>Manhattan plot of the r-XCI approach.</title><p>Association results of <bold>a</bold> the meta-analysis including AD-proxy cases, <bold>b</bold> the diagnosed AD cases meta-analysis and <bold>c</bold> the meta-analysis excluding biobanks. The red and blue lines represent the genome-wide significant threshold (5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>) and the X-chromosome-wide significant threshold (1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>), respectively. The labels show the closest protein-coding gene (according to GENCODE release 45, <ext-link ext-link-type="uri" xlink:href="https://www.gencodegenes.org/human/releases.html">https://www.gencodegenes.org/human/releases.html</ext-link>) to the index variant of each X-chromosome-wide significant locus.</p></caption><graphic xlink:href="41380_2024_2838_Fig2_HTML" id="d33e3999"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><title>Manhattan plot of the e-XCI approach.</title><p>Association results of <bold>a</bold> the diagnosed AD-cases meta-analysis and <bold>b</bold> the meta-analysis excluding biobanks. The red and blue lines represent the genome-wide significant threshold (5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>) and the X-chromosome-wide significant threshold (1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>), respectively.</p></caption><graphic xlink:href="41380_2024_2838_Fig3_HTML" id="d33e4018"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><title>Manhattan plot of the s-XCI approach meta-analysis, which excludes biobanks.</title><p>The red and blue lines represent the genome-wide significant threshold (5&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;8</sup>) and the X-chromosome-wide significant threshold (1.6&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>), respectively.</p></caption><graphic xlink:href="41380_2024_2838_Fig4_HTML" id="d33e4031"/></fig><table-wrap id="Tab1"><label>Table 1</label><caption><p>Summary of association analysis results with an X-chromosome-wide significant signal.</p></caption><table frame="hsides" rules="groups"><thead><tr><th/><th/><th/><th/><th/><th/><th/><th/><th colspan="4">Main analysis</th><th colspan="4">Sex-adjusted</th></tr><tr><th>Variant<sup>a</sup></th><th>Model</th><th>Meta-analysis</th><th>Position<sup>b</sup></th><th>Gene<sup>c</sup></th><th>Inactivation status<sup>d</sup></th><th>Minor/major allele</th><th>MAF<sup>e</sup></th><th>OR<sup>f</sup></th><th>95% CI</th><th><italic>p</italic> value</th><th><italic>I</italic><sup>2</sup></th><th>OR<sup>f</sup></th><th>95% CI</th><th><italic>p</italic> value</th><th><italic>I</italic><sup>2</sup></th></tr></thead><tbody><tr><td colspan="16">Common variants (MAF&#x02009;&#x0003e;&#x02009;0.01)</td></tr><tr><td>&#x02003;rs4364769</td><td valign="middle" rowspan="4">r-XCI</td><td rowspan="2">AD-proxy</td><td>5,462,201</td><td><italic>NLGN4X</italic> (Xp22.32)</td><td>Variable</td><td>T/G</td><td>0.12</td><td>1.079</td><td>1.048&#x02013;1.110</td><td>2.55&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup></td><td>0</td><td>1.074</td><td>1.043&#x02013;1.107</td><td>1.52&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0.0</td></tr><tr><td>&#x02003;rs5933929</td><td>11,916,372</td><td><italic>FRMPD4</italic></td><td>Inactive</td><td>C/A</td><td>0.38</td><td>0.952</td><td>0.935&#x02013;0.970</td><td>1.98&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup></td><td>0</td><td>0.951</td><td>0.933&#x02013;0.969</td><td>2.01&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup></td><td>0.0</td></tr><tr><td>&#x02003;rs5972406</td><td>excluding biobanks</td><td>31,546,147</td><td><italic>DMD</italic></td><td>Inactive</td><td>A/G</td><td>0.08</td><td>1.143</td><td>1.083&#x02013;1.207</td><td>1.16&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0</td><td>1.131</td><td>1.066&#x02013;1.200</td><td>4.38&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup></td><td>0.0</td></tr><tr><td>&#x02003;rs191195705</td><td>AD-proxy</td><td>122,643,733</td><td><italic>GRIA3</italic> (Xq25)</td><td>NA</td><td>A/C</td><td>0.11</td><td>0.925</td><td>0.896&#x02013;0.954</td><td>7.09&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup></td><td>12.3</td><td>0.922</td><td>0.894&#x02013;0.952</td><td>6.71&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup></td><td>10.5</td></tr><tr><td colspan="16">Rare variants (MAF&#x02009;&#x02264;&#x02009;0.01)</td></tr><tr><td rowspan="2">&#x02003;rs189139822</td><td>r-XCI</td><td rowspan="2">AD-Diagnosed</td><td rowspan="2">54,307,465</td><td rowspan="2"><italic>WNK3</italic></td><td rowspan="2">Inactive</td><td rowspan="2">A/G</td><td>9.70&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>1.481</td><td>1.263&#x02013;1.735</td><td>1.29&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0</td><td>1.475</td><td>1.251&#x02013;1.739</td><td>3.67&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>29.7</td></tr><tr><td>e-XCI</td><td>9.10&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>1.343</td><td>1.192&#x02013;1.513</td><td>1.20&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>15.2</td><td/><td/><td/><td/></tr><tr><td>&#x02003;rs771148434</td><td rowspan="2">r-XCI</td><td>AD-proxy</td><td>69,290,372</td><td><italic>PJA1</italic></td><td>Inactive</td><td>G/A</td><td>8.00&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup></td><td>3.107</td><td>1.967&#x02013;4.910</td><td>1.18&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0</td><td>3.185</td><td>1.986&#x02013;5.109</td><td>1.54&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0.0</td></tr><tr><td>&#x02003;rs1326297223</td><td>AD-Diagnosed</td><td>86,293,721</td><td><italic>DACH2</italic></td><td>Variable</td><td>A/T</td><td>2.10&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup></td><td>2.281</td><td>1.629&#x02013;3.192</td><td>1.56&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0</td><td>2.642</td><td>1.758&#x02013;3.970</td><td>2.91&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup></td><td>0.0</td></tr></tbody></table><table-wrap-foot><p><italic>p</italic> values are two-sided raw <italic>p</italic> values derived from a fixed-effect meta-analysis.</p><p><italic>CI</italic> confidence interval, <italic>OR</italic> odds ratio, <italic>MAF</italic> minor allele frequency.</p><p><sup>a</sup>Reference single-nucleotide polymorphism (SNP) (rs) number, according to dbSNP build 153.</p><p><sup>b</sup>GRCh38 assembly.</p><p><sup>c</sup>Nearest protein-coding gene according to GENCODE release 45.</p><p><sup>d</sup>From Tukiainen et al. [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p><sup>e</sup>Weighted average MAF across all discovery studies.</p><p><sup>f</sup>Approximate OR calculated with respect to the minor allele.</p></table-wrap-foot></table-wrap></p><p id="Par30">In the sensitivity models including only diagnosed AD-cases or excluding biobank samples, we did not identify any genome-wide significant signals among X-chromosome variants either (Figs.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref> and Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref> and <xref rid="MOESM1" ref-type="media">S2</xref>). However, we identified an X-chromosome-wide significant signal at a common index variant in the <italic>DMD</italic> locus in the r-XCI meta-analysis excluding biobanks, and at two rare index variants in the <italic>WNK3</italic> and <italic>DACH2</italic> genes in the r-XCI meta-analysis excluding AD-proxy cases (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).</p><p id="Par31">In either the male-only or female-only meta-analyses, we did not identify any genome-wide nor X-chromosome-wide significant signals (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>). We also did not observe any genome-wide nor X-chromosome-wide significant difference of effect between males and females for any X-chromosome variants (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S4</xref>).</p></sec><sec id="Sec14"><title>Detailed description of the X-chromosome-wide significant loci</title><p id="Par32">In more details, rs4364769 (MAF&#x02009;=&#x02009;0.12, OR&#x02009;=&#x02009;1.079 [1.048&#x02013;1.110], P&#x02009;=&#x02009;2.55&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup>) was identified as the index variant of the Xp22.32 locus in the r-XCI meta-analysis (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S5</xref>). The odds-ratio estimate of rs4364769 shows some variability across sensitivity analyses but confidence intervals overlap (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>). The index variant of the Xp22.32 signal is located more than 300&#x02009;kb from the closest protein coding gene, <italic>NLGN4X</italic> (Neuroligin 4 X-Linked).</p><p id="Par33">The index variant in the <italic>FRMPD4</italic> (FERM and PDZ Domain Containing 4) locus was rs5933929 (MAF&#x02009;=&#x02009;0.38, OR&#x02009;=&#x02009;0.952 [0.935&#x02013;0.970], P&#x02009;=&#x02009;1.98&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup>) in the r-XCI meta-analysis (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S6</xref>). This variant is located in an intron within some transcripts of <italic>FRMPD4</italic>. The odds-ratio of rs5933929 was consistent across sensitivity analyses (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>).</p><p id="Par34">The common variant rs5972406, located in an intron of the <italic>DMD</italic> dystrophin gene, was X-chromosome-wide significant only in the r-XCI meta-analysis excluding biobanks (MAF&#x02009;=&#x02009;0.075, OR&#x02009;=&#x02009;1.143 [1.083&#x02013;1.207], P&#x02009;=&#x02009;1.16&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S7</xref>). The odds-ratio estimate was lower in the analysis including AD-proxy cases (OR&#x02009;=&#x02009;1.075 [1.037&#x02013;1.113], P&#x02009;=&#x02009;6.75&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>), but confidence intervals overlap (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>).</p><p id="Par35">rs191195705 was the index variant in the Xq25 signal in the r-XCI meta-analysis (MAF&#x02009;=&#x02009;0.11, OR&#x02009;=&#x02009;0.925 [0.896&#x02013;0.954], P&#x02009;=&#x02009;7.09&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;7</sup>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S8</xref>). Here the males and the UKB-proxy males carried a large part of the observed effect, leading to a lower signal in the sensitivity analyses excluding proxy or biobank cases, or in the female-only compared to the male-only meta-analyses (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S8</xref>). However, the difference of effect between males and females was not significant (P&#x02009;=&#x02009;0.51, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>). rs191195705 is over 500&#x02009;kb from the closest protein coding gene, <italic>GRIA3</italic> (Glutamate Ionotropic Receptor AMPA Type Subunit 3).</p><p id="Par36">Other signals had rare index variants which were not analyzed in the ADGC and CHARGE studies, due to their smaller sample sizes (Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S9</xref>&#x02013;<xref rid="MOESM1" ref-type="media">S12</xref>). rs189139822, located in an intron of <italic>WNK3</italic>, was identified in the r-XCI (MAF&#x02009;=&#x02009;9.70&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>, OR&#x02009;=&#x02009;1.481 [1.263&#x02013;1.735], P&#x02009;=&#x02009;1.29&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>) and e-XCI (MAF&#x02009;=&#x02009;9.10&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>, OR&#x02009;=&#x02009;1.343 [1.192&#x02013;1.513], P&#x02009;=&#x02009;1.20&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>) meta-analyses excluding AD-proxy cases (Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S8</xref>). The odds-ratio of rs189139822 was consistent across studies and sensitivity analyses (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>). However, the imputation quality for the variant was low (r<sup>2</sup>&#x02009;&#x0003c;&#x02009;0.6) in many studies (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S8</xref>).</p><p id="Par37">rs771148434, the index variant of the <italic>PJA1</italic> (Praja Ring Finger Ubiquitin Ligase 1) signal, was very rare (MAF&#x02009;=&#x02009;8.00&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>) and analyzed only in the EADB-core and UKB-proxy studies. Detected in the r-XCI meta-analysis (OR&#x02009;=&#x02009;3.107 [1.967&#x02013;4.910], P&#x02009;=&#x02009;1.18&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S10</xref>), this variant was excluded from most of the sensitivity analyses due to its rarity (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>).</p><p id="Par38">The rs1326297223 index variant is located in an intron of <italic>DACH2</italic>. It was identified in the r-XCI meta-analysis excluding AD-proxy cases (MAF&#x02009;=&#x02009;2.10&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>, OR&#x02009;=&#x02009;2.281 [1.629&#x02013;3.192], P&#x02009;=&#x02009;1.56&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;6</sup>, Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref> and Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S11</xref>), and its odds-ratio was consistent across studies and sensitivity analyses (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>).</p><p id="Par39">Three rare variants, all in high LD (r<sup>2</sup>&#x02009;&#x0003e;&#x02009;0.8), were associated at the X-chromosome-wide significance threshold with AD-risk in the <italic>TMEM187-G6PD/IKBKG</italic> (Transmembrane Protein 187, Glucose-6-Phosphate Dehydrogenase and Inhibitor Of Nuclear Factor Kappa B Kinase Regulatory Subunit Gamma) locus (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S10</xref>). They were only analyzed in the EADB-core and UKB-proxy studies, but the signal was heterogeneous across studies (I<sup>2</sup>&#x02009;=&#x02009;56.5 for the index variant rs782044000, Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S12</xref>), and carried mainly by EADB-core. In this study, most carriers were from Italy and Greece, and the signal disappeared when excluding Greek samples (P&#x02009;=&#x02009;0.43 for rs782044000), or when meta-analyzing the per-country results in EADB-core (P&#x02009;=&#x02009;0.12 for rs782044000, <xref rid="MOESM1" ref-type="media">Supplementary Material</xref>). One of the three index variants, rs5030868, is the G6PD Mediterranean mutation, which is much more frequent in the Mediterranean region than in the rest of Europe [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>]. We thus considered this signal to be falsely inflated in EADB-core due to this population structure.</p></sec><sec id="Sec15"><title>Biomarker and cognitive decline associations</title><p id="Par40">We further investigated the association of the common index variants of the suggestive signals with CSF biomarkers and cognitive decline. We found no significant association (P&#x02009;&#x0003c;&#x02009;4.17&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>) with A&#x003b2;<sub>42</sub> or pTau with any common index variant, whatever the approach (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S11</xref>), but the <italic>FRMPD4</italic> index variant rs5933929 was significantly associated with cognitive decline in both the r-XCI and e-XCI approaches (P&#x02009;=&#x02009;2.75&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> and 3.30&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup> respectively), and the direction of effect of the cognitive decline and AD-risk associations were consistent (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S12</xref>).</p></sec><sec id="Sec16"><title>Colocalization with brain tissue eQTL and pQTL</title><p id="Par41">We did not find any significant colocalization of our AD association signals with any brain tissue eQTL or pQTL signal (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S13</xref>).</p></sec><sec id="Sec17"><title>Differential expression and methylation</title><p id="Par42">We also examined expression and methylation data of the genes within the suggestive loci.</p><p id="Par43">The genes <italic>FRMPD4</italic> (in males)<italic>, GRIA3</italic> (Xq25, in females)<italic>, TSR2</italic> (in the <italic>WNK3</italic> locus), and <italic>EDA</italic> (in the <italic>PJA1</italic> locus) showed significant differential expression (P&#x02009;&#x0003c;&#x02009;1.32&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;3</sup>) in temporal lobe tissue (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S14</xref>). Expression of <italic>EDA</italic> was also significantly associated with AD status in female pre-frontal cortex tissue. Amyloid plaque burden was found to be significantly associated (P&#x02009;&#x0003c;&#x02009;4.39&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>) with methylation changes in <italic>FRMPD4</italic>, <italic>ARHGAP6</italic> (in the <italic>FRMPD4</italic> locus), and <italic>DMD</italic>.</p></sec><sec id="Sec18"><title>XLID gene enrichment</title><p id="Par44">All the suggestive loci contain XLID putative causal genes, except <italic>DACH2</italic>. However, we did not detect an enrichment of the AD association signals in the XLID genes in any of the analyses (P&#x02009;=&#x02009;0.37, 0.33 and 0.53 in r-XCI, e-XCI and s-XCI approaches, respectively).</p></sec></sec><sec id="Sec19" sec-type="discussion"><title>Discussion</title><p id="Par45">We conducted the most comprehensive XWAS on AD to date, including 115,841 AD or AD-proxy cases and 613,671 controls and using three complementary models to account for the complexity related to the X-chromosome. Importantly, 52,214 clinically diagnosed AD cases were included, allowing to assess the impact of proxy-AD or biobank cases on the results. Despite not detecting any genome-wide significant signals regardless of the approach used, seven X-chromosome-wide significant loci passed our post-analysis QC. Index variants were common in four loci; the signal in the <italic>FRMPD4</italic> locus was consistent across the sensitivity analyses, showing strong robustness, while the other signals in Xp22.32 (<italic>NLGN4X</italic>), Xq25 (<italic>GRIA3</italic>) and <italic>DMD</italic> showed some variability. Robustness of the results was more difficult to assess for the rare index variants of the <italic>WNK3</italic>, <italic>PJA1</italic>, and <italic>DACH2</italic> loci.</p><p id="Par46"><italic>FRMPD4</italic> (FERM and PDZ domain containing 4) is mostly expressed in brain tissues (GTex Portal, <ext-link ext-link-type="uri" xlink:href="https://gtexportal.org/">https://gtexportal.org/</ext-link>), and showed differential expression in male temporal lobe between AD cases and controls. Through its interaction with other proteins, the FRMPD4 protein is involved in the regulation of the morphogenesis and density of dendritic spines, and in the maintenance of excitatory synaptic transmission [<xref ref-type="bibr" rid="CR76">76</xref>]. <italic>FRMPD4</italic> is an X-linked intellectual disability gene [<xref ref-type="bibr" rid="CR77">77</xref>] and is associated with low educational attainment [<xref ref-type="bibr" rid="CR78">78</xref>]. The association of the index variant of the <italic>FRMPD4</italic> locus with cognitive decline could thus be linked to a lower cognitive reserve. The associated variant is in an intron within some transcripts of <italic>FRMPD4</italic> but is also close to the <italic>MSL3</italic> gene, which interacts with <italic>KAT8</italic>, a reported genetic risk factor for AD [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR80">80</xref>]. In addition, <italic>FRMPD4</italic> is an inactivated gene in females, while <italic>MSL3</italic> escapes inactivation [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par47">The signal at the intronic variant within the <italic>DMD</italic> dystrophin gene decreased when including proxy or biobank cases; further analyses are necessary to determine whether this is due to a falsely inflated signal in the clinically diagnosed samples, or to a less specific diagnosis in the proxy and biobank samples. <italic>DMD</italic> is inactivated in females [<xref ref-type="bibr" rid="CR13">13</xref>], and mutations in the gene can cause Duchenne muscular dystrophy. Some patients suffering from this disease can exhibit cognitive impairment, and a shift towards amyloidogenesis in memory-specific brain regions was found in mice mutated in the <italic>DMD</italic> gene (mdx mouse) compared to wild-type mice [<xref ref-type="bibr" rid="CR81">81</xref>]. Additionally, the <italic>DMD</italic> rs5927116 variant was reportedly associated with the volume of entorhinal cortex in a small sample (N&#x02009;=&#x02009;792); however, this signal is 1.4&#x02009;Mb away from our AD signal and the variants are independent (LD measured by r<sup>2</sup>&#x02009;=&#x02009;1.65&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;4</sup>) [<xref ref-type="bibr" rid="CR82">82</xref>].</p><p id="Par48">The rare variant signals in the <italic>WNK3</italic> and <italic>PJA1</italic> loci are characterized by a low imputation quality or a limited number of clinically diagnosed AD cases analyzed, and further analyses in sequencing data would be necessary to validate those signals. Inhibition of WNK3 is reportedly neuroprotective in stroke [<xref ref-type="bibr" rid="CR83">83</xref>] and intracerebral hemorrhage [<xref ref-type="bibr" rid="CR84">84</xref>], but has a deleterious effect on neurons after traumatic brain injury [<xref ref-type="bibr" rid="CR85">85</xref>]. In the <italic>PJA1</italic> locus, the index variant is located in an enhancer between the <italic>PJA1</italic> and <italic>NALF2</italic> (NALCN Channel Auxiliary Factor 2) genes. Variants in this locus are associated with educational attainment [<xref ref-type="bibr" rid="CR78">78</xref>], and <italic>PJA1</italic> is expressed in the brain. Another rare variant signal was identified in the <italic>DACH2</italic> gene, which is associated with brain shape (segment 7) [<xref ref-type="bibr" rid="CR86">86</xref>] and edge-level brain connectivity measures [<xref ref-type="bibr" rid="CR87">87</xref>].</p><p id="Par49">Identifying putative causal genes in the two other loci, Xp22.32 and Xq25, is more challenging, as the index variants are located more than 300&#x02009;kb away from the closest protein coding gene, <italic>NLGN4X</italic> and <italic>GRIA3</italic>, respectively. Additionally, those variants are not eQTL/sQTL for any gene according to GTeX Portal. Expression of the <italic>GRIA3</italic> gene in temporal lobe is associated with AD risk in females, and its expression in the dorsolateral prefrontal cortex is reportedly associated with cognitive change in women during aging and AD [<xref ref-type="bibr" rid="CR47">47</xref>]. However, the rs191195705 index variant of the Xq25 signal is associated with AD risk mainly in males in our analyses (Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S8</xref>). Regarding the Xp22.32 locus, the rs5916169 variant, located at 127&#x02009;kb from our index variant, is associated with functional connectivity [<xref ref-type="bibr" rid="CR16">16</xref>]. However, this variant is not in LD (r<sup>2</sup>&#x02009;=&#x02009;0.005) with the AD index variant.</p><p id="Par50">Different X-chromosome-wide significant loci were detected in the main analysis&#x02014;considering AD-proxy cases&#x02014; and in the sensitivity ones including only diagnosed AD-cases or excluding biobank samples. A loss of significance was expected in the sensitivity analyses compared to the main analysis due to lower power; similar odds-ratio and overlapping confidence intervals should however be observed for signals mainly driven by AD rather than non-AD dementia. This was the case for the <italic>FRMPD4</italic> locus, and to a lesser extent for the Xp22.32 and Xq25 loci. The loss of a signal in the sensitivity analyses might also be due to purely analytical reasons; for example, the rare index variant of the <italic>PJA1</italic> locus did not pass the filtering criteria in the sensitivity analyses. The identification of the <italic>DMD</italic>, <italic>WNK3</italic> and <italic>DACH2</italic> loci in the sensitivity analyses but not in the main analysis, despite its higher power, might be due to sampling variation, a dilution of the signal in the main analysis linked to the expected higher proportion of non-AD dementia cases among AD-proxy cases or a falsely inflated signal in the sensitivity analyses. Additionally, the correction factor used in the UKB proxy analysis was designed for common variants with low to moderate effect. It might be less appropriate for rare variants with larger effects, such as the index variants of the <italic>WNK3</italic> and <italic>DACH2</italic> loci. Further studies in larger samples will help to delineate the real impact of those loci on AD risk.</p><p id="Par51">Although this study represents a powerful XWAS for AD, we did not find any genome-wide-significant genetic association with AD risk among X-chromosome variants. A recent XWAS on AD identified only one genome-wide significant association in the <italic>SLC9A7</italic> locus [<xref ref-type="bibr" rid="CR88">88</xref>]. We do not replicate this result at the X-chromosome-wide significance level (OR&#x02009;=&#x02009;1.023 [1.005&#x02013;1.042], P&#x02009;=&#x02009;1.36&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;2</sup> for the index variant rs2142791, and minimum P in the locus of 5.2&#x02009;&#x000d7;&#x02009;10<sup>&#x02212;5</sup>, in the r-XCI meta-analysis including AD-proxy cases, Supplementary Table&#x000a0;<xref rid="MOESM2" ref-type="media">S15</xref>). The lack of signal overlap between the two studies may be explained in part by a different definition of AD and AD-proxy status, leading to an expected higher proportion of non-AD dementia cases in the other study (<xref rid="MOESM1" ref-type="media">Supplementary Material</xref>).</p><p id="Par52">Technical or analytical reasons can partly explain the absence of genome-wide significant signals on the X-chromosome, such as: 1) overall lower variant density, 2) lower coverage by genotyping platforms, 3) lower call rate of variants, 4) lower imputation quality, or 5) a lower effective sample size in males on the X-chromosome compared to the autosomes [<xref ref-type="bibr" rid="CR89">89</xref>]. However, it is also possible that fewer genome-wide significant associations of X-chromosome loci with AD risk exist than on autosomes due to a lower density of functional variants on the X-chromosome. Indeed, Gorlov et al. 2023 [<xref ref-type="bibr" rid="CR89">89</xref>] found a lower density of variants in both exonic and intronic regions on the X-chromosome compared to autosomes, which they link to a stronger selection against X-chromosome mutations.</p><p id="Par53">In conclusion, this XWAS found no common genetic risk factor for AD on the non-pseudoautosomal region of the X-chromosome but identified suggestive signals with moderate impact on AD risk, which warrant further investigations. In particular, future analyses of sequencing data will help to address some of the technical issues described above, and will allow to study the impact of X-chromosome rare variants or structural variants on AD risk. Additionally, extending XWAS to AD-related phenotypes, such as cognitive decline, AD pathology or AD biomarkers, would further delineate the impact of X-chromosome genetic variations on the processes leading to AD. Lastly, insights into the contribution of the X-chromosome to AD or AD-related phenotypes will be provided by additional studies of the impact of X-chromosome biology beyond genetic variations, for example gene expression or epigenetic alterations, including parental imprinting [<xref ref-type="bibr" rid="CR49">49</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR91">91</xref>].</p></sec><sec id="Sec20" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41380_2024_2838_MOESM1_ESM.pdf"><caption><p>Supplementary Material</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41380_2024_2838_MOESM2_ESM.xlsx"><caption><p>Supplementary Tables</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>These authors contributed equally: Julie Le Borgne, Lissette Gomez.</p></fn><fn><p>These authors jointly supervised this work: Brian Kunkle, C&#x000e9;line Bellenguez.</p></fn><fn><p>A list of members and their affiliations appears in the Supplementary Information.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41380-024-02838-5.</p></sec><ack><title>Acknowledgements</title><p>EADB: This study was supported by grants from the Fondation pour la Recherche sur Alzheimer (convention 2022-A-01 and cluster grant), and the JPco-fuND-2 &#x02018;Multinational research projects on Personalized Medicine for Neurodegenerative Diseases&#x02019; PREADAPT project (ANR-19-JPW2-0004). We thank the many study participants, researchers and staff for collecting and contributing to the data, the high-performance computing service at the University of Lille and the staff at CEA-CNRGH for their help with sample preparation and genotyping and excellent technical assistance. We thank Antonio Pardinas for his help. We thank the Netherlands Brain Bank. This research was conducted using the UKBB resource (application number 61054). This work was funded by a grant (EADB) from the EU Joint Programme&#x02014;Neurodegenerative Disease Research. Inserm UMR1167 is also funded by the Inserm, Institut Pasteur de Lille, Lille M&#x000e9;tropole Communaut&#x000e9; Urbaine and French government&#x02019;s LABEX DISTALZ program (Development of Innovative Strategies for a Transdisciplinary Approach to ALZheimer&#x02019;s disease). This work was also supported by the Research Council of Finland grants 338182 and 334802, the Sigrid Jus&#x000e9;lius Foundation, and the Strategic Neuroscience Funding of the University of Eastern Finland. ADGC: The National Institutes of Health, National Institute on Aging (NIH-NIA) supported this work through the following grants: ADGC, U01 AG032984, RC2 AG036528; Samples from the National Cell Repository for Alzheimer&#x02019;s Disease (NCRAD), which receives government support under a cooperative agreement grant (U24 AG21886) awarded by the National Institute on Aging (NIA), were used in this study. We thank contributors who collected samples used in this study, as well as patients and their families, whose help and participation made this work possible. Data for this study were prepared, archived, and distributed by the National Institute on Aging Alzheimer&#x02019;s Disease Data Storage Site (NIAGADS) at the University of Pennsylvania (U24-AG041689-01) in cooperation with NACC (U24 AG072122) and additional studies described in the&#x000a0;<xref rid="MOESM1" ref-type="media">Supplementary Materials</xref>. Full consortium acknowledgments and funding are in the&#x000a0;<xref rid="MOESM1" ref-type="media">Supplementary Materials</xref>.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Coordination: BK and CB. Data analyses: JLB, LG, SH, NA, SA, SHC, JB, BG-B, OGR, LK, JY, KPT, LW, AV, RC-M, SvdL, VD, IdR, SP, AD, JD, BK and CB. Core writing group: JLB, J-CL, BK and CB. All other authors contributed samples and data.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Summary statistics are available through the European Bioinformatics Institute GWAS Catalog (<ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/gwas/">https://www.ebi.ac.uk/gwas/</ext-link>) under study accessions GCST90449045 to GCST90449052.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>We used publicly available software for all analyses, which are listed in the&#x000a0;<xref rid="MOESM1" ref-type="media">Supplementary Materials</xref> with their appropriate citations. We also provide command lines in the Supplementary Materials appendix, and some specific scripts on Zenodo (10.5281/zenodo.14001011).</p></notes><notes id="FPar5" notes-type="COI-statement"><title>Competing interests</title><p id="Par54">The authors declare no competing interests.</p></notes><notes id="FPar6"><title>Ethics approval and consent to participate</title><p id="Par55">Written informed consent was obtained from study participants or, for those with substantial cognitive impairment, a caregiver, legal guardian or other proxy. Study protocols for all cohorts were reviewed and approved by the appropriate institutional review boards.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Lambert</surname><given-names>JC</given-names></name><name><surname>Ramirez</surname><given-names>A</given-names></name><name><surname>Grenier-Boley</surname><given-names>B</given-names></name><name><surname>Bellenguez</surname><given-names>C</given-names></name></person-group><article-title>Step by step: towards a better understanding of the genetic architecture of Alzheimer&#x02019;s disease</article-title><source>Mol Psychiatry</source><year>2023</year><volume>28</volume><fpage>2716</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1038/s41380-023-02076-1</pub-id><pub-id pub-id-type="pmid">37131074</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Lambert JC, Ramirez A, Grenier-Boley B, Bellenguez C. Step by step: towards a better understanding of the genetic architecture of Alzheimer&#x02019;s disease. Mol Psychiatry. 2023;28:2716&#x02013;27.<pub-id pub-id-type="pmid">37131074</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Bellenguez</surname><given-names>C</given-names></name><name><surname>K&#x000fc;&#x000e7;&#x000fc;kali</surname><given-names>F</given-names></name><name><surname>Jansen</surname><given-names>IE</given-names></name><name><surname>Kleineidam</surname><given-names>L</given-names></name><name><surname>Moreno-Grau</surname><given-names>S</given-names></name><name><surname>Amin</surname><given-names>N</given-names></name><etal/></person-group><article-title>New insights into the genetic etiology of Alzheimer&#x02019;s disease and related dementias</article-title><source>Nat Genet</source><year>2022</year><volume>54</volume><fpage>412</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01024-z</pub-id><pub-id pub-id-type="pmid">35379992</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Bellenguez C, K&#x000fc;&#x000e7;&#x000fc;kali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer&#x02019;s disease and related dementias. Nat Genet. 2022;54:412&#x02013;36.<pub-id pub-id-type="pmid">35379992</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, et al. Exome sequencing identifies rare damaging variants in <italic>ATP8B4</italic> and <italic>ABCA1</italic> as risk factors for Alzheimer&#x02019;s disease. Nat Genet. 2022;54:1786&#x02013;94</mixed-citation></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Kunkle</surname><given-names>BW</given-names></name><name><surname>Grenier-Boley</surname><given-names>B</given-names></name><name><surname>Sims</surname><given-names>R</given-names></name><name><surname>Bis</surname><given-names>JC</given-names></name><name><surname>Damotte</surname><given-names>V</given-names></name><name><surname>Naj</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Genetic meta-analysis of diagnosed Alzheimer&#x02019;s disease identifies new risk loci and implicates A&#x003b2;, tau, immunity and lipid processing</article-title><source>Nat Genet</source><year>2019</year><volume>51</volume><fpage>414</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1038/s41588-019-0358-2</pub-id><pub-id pub-id-type="pmid">30820047</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC, et al. Genetic meta-analysis of diagnosed Alzheimer&#x02019;s disease identifies new risk loci and implicates A&#x003b2;, tau, immunity and lipid processing. Nat Genet. 2019;51:414&#x02013;30.<pub-id pub-id-type="pmid">30820047</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Wightman</surname><given-names>DP</given-names></name><name><surname>Jansen</surname><given-names>IE</given-names></name><name><surname>Savage</surname><given-names>JE</given-names></name><name><surname>Shadrin</surname><given-names>AA</given-names></name><name><surname>Bahrami</surname><given-names>S</given-names></name><name><surname>Holland</surname><given-names>D</given-names></name><etal/></person-group><article-title>A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x02019;s disease</article-title><source>Nat Genet</source><year>2021</year><volume>53</volume><fpage>1276</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1038/s41588-021-00921-z</pub-id><pub-id pub-id-type="pmid">34493870</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Wightman DP, Jansen IE, Savage JE, Shadrin AA, Bahrami S, Holland D, et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer&#x02019;s disease. Nat Genet. 2021;53:1276&#x02013;82.<pub-id pub-id-type="pmid">34493870</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Sims</surname><given-names>R</given-names></name><name><surname>Van Der Lee</surname><given-names>SJ</given-names></name><name><surname>Naj</surname><given-names>AC</given-names></name><name><surname>Bellenguez</surname><given-names>C</given-names></name><name><surname>Badarinarayan</surname><given-names>N</given-names></name><name><surname>Jakobsdottir</surname><given-names>J</given-names></name><etal/></person-group><article-title>Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer&#x02019;s disease</article-title><source>Nat Genet</source><year>2017</year><volume>49</volume><fpage>1373</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1038/ng.3916</pub-id><pub-id pub-id-type="pmid">28714976</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Sims R, Van Der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer&#x02019;s disease. Nat Genet. 2017;49:1373&#x02013;84.<pub-id pub-id-type="pmid">28714976</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="other">Carrel L, Brown CJ. When the lyon(Ized chromosome) roars: ongoing expression from an inactive X chromosome. Philos Trans R Soc B Biol Sci. 2017;372:20160355.</mixed-citation></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>MF</given-names></name></person-group><article-title>Gene action in the X-chromosom (Mus musculus L.)</article-title><source>Nature</source><year>1961</year><volume>190</volume><fpage>372</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1038/190372a0</pub-id><pub-id pub-id-type="pmid">13764598</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Lyon MF. Gene action in the X-chromosom (Mus musculus L.). Nature. 1961;190:372&#x02013;3.<pub-id pub-id-type="pmid">13764598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Amos-Landgraf</surname><given-names>JM</given-names></name><name><surname>Cottle</surname><given-names>A</given-names></name><name><surname>Plenge</surname><given-names>RM</given-names></name><name><surname>Friez</surname><given-names>M</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name><name><surname>Longshore</surname><given-names>J</given-names></name><etal/></person-group><article-title>X chromosome-inactivation patterns of 1,005 phenotypically unaffected females</article-title><source>Am J Hum Genet</source><year>2006</year><volume>79</volume><fpage>493</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1086/507565</pub-id><pub-id pub-id-type="pmid">16909387</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Amos-Landgraf JM, Cottle A, Plenge RM, Friez M, Schwartz CE, Longshore J, et al. X chromosome-inactivation patterns of 1,005 phenotypically unaffected females. Am J Hum Genet. 2006;79:493&#x02013;9.<pub-id pub-id-type="pmid">16909387</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Shvetsova</surname><given-names>E</given-names></name><name><surname>Sofronova</surname><given-names>A</given-names></name><name><surname>Monajemi</surname><given-names>R</given-names></name><name><surname>Gagalova</surname><given-names>K</given-names></name><name><surname>Draisma</surname><given-names>HHM</given-names></name><name><surname>White</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Skewed X-inactivation is common in the general female population</article-title><source>Eur J Hum Genet</source><year>2019</year><volume>27</volume><fpage>455</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1038/s41431-018-0291-3</pub-id><pub-id pub-id-type="pmid">30552425</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Shvetsova E, Sofronova A, Monajemi R, Gagalova K, Draisma HHM, White SJ, et al. Skewed X-inactivation is common in the general female population. Eur J Hum Genet. 2019;27:455&#x02013;65.<pub-id pub-id-type="pmid">30552425</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Zito</surname><given-names>A</given-names></name><name><surname>Davies</surname><given-names>MN</given-names></name><name><surname>Tsai</surname><given-names>PC</given-names></name><name><surname>Roberts</surname><given-names>S</given-names></name><name><surname>Andres-Ejarque</surname><given-names>R</given-names></name><name><surname>Nardone</surname><given-names>S</given-names></name><etal/></person-group><article-title>Heritability of skewed X-inactivation in female twins is tissue-specific and associated with age</article-title><source>Nat Commun</source><year>2019</year><volume>10</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41467-019-13340-w</pub-id><pub-id pub-id-type="pmid">30602773</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Zito A, Davies MN, Tsai PC, Roberts S, Andres-Ejarque R, Nardone S, et al. Heritability of skewed X-inactivation in female twins is tissue-specific and associated with age. Nat Commun. 2019;10:1&#x02013;11.<pub-id pub-id-type="pmid">30602773</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Busque</surname><given-names>L</given-names></name><name><surname>Mio</surname><given-names>R</given-names></name><name><surname>Mattioli</surname><given-names>J</given-names></name><name><surname>Brais</surname><given-names>E</given-names></name><name><surname>Biais</surname><given-names>N</given-names></name><name><surname>Lalonde</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Nonrandom X-inactivation patterns in normal females: Lyonization ratios vary with age</article-title><source>Blood</source><year>1996</year><volume>88</volume><fpage>59</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1182/blood.V88.1.59.59</pub-id><pub-id pub-id-type="pmid">8704202</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Busque L, Mio R, Mattioli J, Brais E, Biais N, Lalonde Y, et al. Nonrandom X-inactivation patterns in normal females: Lyonization ratios vary with age. Blood. 1996;88:59&#x02013;65.<pub-id pub-id-type="pmid">8704202</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Tukiainen</surname><given-names>T</given-names></name><name><surname>Villani</surname><given-names>AC</given-names></name><name><surname>Yen</surname><given-names>A</given-names></name><name><surname>Rivas</surname><given-names>MA</given-names></name><name><surname>Marshall</surname><given-names>JL</given-names></name><name><surname>Satija</surname><given-names>R</given-names></name><etal/></person-group><article-title>Landscape of X chromosome inactivation across human tissues</article-title><source>Nature</source><year>2017</year><volume>550</volume><fpage>244</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/nature24265</pub-id><pub-id pub-id-type="pmid">29022598</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Tukiainen T, Villani AC, Yen A, Rivas MA, Marshall JL, Satija R, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550:244&#x02013;8.<pub-id pub-id-type="pmid">29022598</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>T</given-names></name><name><surname>Manolio</surname><given-names>TA</given-names></name><name><surname>Paterson</surname><given-names>AD</given-names></name></person-group><article-title>eXclusionarY: 10 years later, where are the sex chromosomes in GWASs?</article-title><source>Am J Hum Genet</source><year>2023</year><volume>110</volume><fpage>903</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2023.04.009</pub-id><pub-id pub-id-type="pmid">37267899</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Sun L, Wang Z, Lu T, Manolio TA, Paterson AD. eXclusionarY: 10 years later, where are the sex chromosomes in GWASs? Am J Hum Genet. 2023;110:903&#x02013;12.<pub-id pub-id-type="pmid">37267899</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>B</given-names></name><name><surname>Craiu</surname><given-names>RV</given-names></name><name><surname>Strug</surname><given-names>LJ</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name></person-group><article-title>The X factor: a robust and powerful approach to X-chromosome-inclusive whole-genome association studies</article-title><source>Genet Epidemiol</source><year>2021</year><volume>45</volume><fpage>694</fpage><lpage>709</lpage><pub-id pub-id-type="doi">10.1002/gepi.22422</pub-id><pub-id pub-id-type="pmid">34224641</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Chen B, Craiu RV, Strug LJ, Sun L. The X factor: a robust and powerful approach to X-chromosome-inclusive whole-genome association studies. Genet Epidemiol. 2021;45:694&#x02013;709.<pub-id pub-id-type="pmid">34224641</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>SM</given-names></name><name><surname>Douaud</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>W</given-names></name><name><surname>Hanayik</surname><given-names>T</given-names></name><name><surname>Alfaro-Almagro</surname><given-names>F</given-names></name><name><surname>Sharp</surname><given-names>K</given-names></name><etal/></person-group><article-title>An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank</article-title><source>Nat Neurosci</source><year>2021</year><volume>24</volume><fpage>737</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1038/s41593-021-00826-4</pub-id><pub-id pub-id-type="pmid">33875891</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Smith SM, Douaud G, Chen W, Hanayik T, Alfaro-Almagro F, Sharp K, et al. An expanded set of genome-wide association studies of brain imaging phenotypes in UK Biobank. Nat Neurosci. 2021;24:737&#x02013;45.<pub-id pub-id-type="pmid">33875891</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Mallard</surname><given-names>TT</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Seidlitz</surname><given-names>J</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Moraczewski</surname><given-names>D</given-names></name><name><surname>Thomas</surname><given-names>A</given-names></name><etal/></person-group><article-title>X-chromosome influences on neuroanatomical variation in humans</article-title><source>Nat Neurosci</source><year>2021</year><volume>24</volume><fpage>1216</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1038/s41593-021-00890-w</pub-id><pub-id pub-id-type="pmid">34294918</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Mallard TT, Liu S, Seidlitz J, Ma Z, Moraczewski D, Thomas A, et al. X-chromosome influences on neuroanatomical variation in humans. Nat Neurosci. 2021;24:1216&#x02013;24.<pub-id pub-id-type="pmid">34294918</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Neri</surname><given-names>G</given-names></name><name><surname>Schwartz</surname><given-names>CE</given-names></name><name><surname>Lubs</surname><given-names>HA</given-names></name><name><surname>Stevenson</surname><given-names>RE</given-names></name></person-group><article-title>XLID update 2017</article-title><source>Am J Med Genet A.</source><year>2018</year><volume>176</volume><fpage>1375</fpage><pub-id pub-id-type="doi">10.1002/ajmg.a.38710</pub-id><pub-id pub-id-type="pmid">29696803</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Neri G, Schwartz CE, Lubs HA, Stevenson RE. XLID update 2017. Am J Med Genet A. 2018;176:1375.<pub-id pub-id-type="pmid">29696803</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Hickman</surname><given-names>RA</given-names></name><name><surname>O&#x02019;Shea</surname><given-names>SA</given-names></name><name><surname>Mehler</surname><given-names>MF</given-names></name><name><surname>Chung</surname><given-names>WK</given-names></name></person-group><article-title>Neurogenetic disorders across the lifespan: from aberrant development to degeneration</article-title><source>Nat Rev Neurol</source><year>2022</year><volume>18</volume><fpage>117</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1038/s41582-021-00595-5</pub-id><pub-id pub-id-type="pmid">34987232</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Hickman RA, O&#x02019;Shea SA, Mehler MF, Chung WK. Neurogenetic disorders across the lifespan: from aberrant development to degeneration. Nat Rev Neurol. 2022;18:117&#x02013;24.<pub-id pub-id-type="pmid">34987232</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>MT</given-names></name><name><surname>Santuccione Chadha</surname><given-names>A</given-names></name></person-group><article-title>The missing X factor in Alzheimer disease</article-title><source>Nat Rev Neurol</source><year>2021</year><volume>17</volume><fpage>727</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/s41582-021-00573-x</pub-id><pub-id pub-id-type="pmid">34635841</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Ferretti MT, Santuccione Chadha A. The missing X factor in Alzheimer disease. Nat Rev Neurol. 2021;17:727&#x02013;8.<pub-id pub-id-type="pmid">34635841</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="other">Alzheimer Europe. Dementia in Europe yearbook 2019: estimating the prevalence of dementia in Europe. Alzheimer Europe; 2019. pp. 108.</mixed-citation></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Nichols</surname><given-names>E</given-names></name><name><surname>Steinmetz</surname><given-names>JD</given-names></name><name><surname>Vollset</surname><given-names>SE</given-names></name><name><surname>Fukutaki</surname><given-names>K</given-names></name><name><surname>Chalek</surname><given-names>J</given-names></name><name><surname>Abd-Allah</surname><given-names>F</given-names></name><etal/></person-group><article-title>Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019</article-title><source>Lancet Public Health.</source><year>2022</year><volume>7</volume><fpage>e105</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(21)00249-8</pub-id><pub-id pub-id-type="pmid">34998485</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105&#x02013;25.<pub-id pub-id-type="pmid">34998485</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Corrada</surname><given-names>MM</given-names></name><name><surname>Brookmeyer</surname><given-names>R</given-names></name><name><surname>Paganini-Hill</surname><given-names>A</given-names></name><name><surname>Berlau</surname><given-names>D</given-names></name><name><surname>Kawas</surname><given-names>CH</given-names></name></person-group><article-title>Dementia incidence continues to increase with age in the oldest old the 90+ study</article-title><source>Ann Neurol</source><year>2010</year><volume>67</volume><fpage>114</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1002/ana.21915</pub-id><pub-id pub-id-type="pmid">20186856</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Corrada MM, Brookmeyer R, Paganini-Hill A, Berlau D, Kawas CH. Dementia incidence continues to increase with age in the oldest old the 90+ study. Ann Neurol. 2010;67:114&#x02013;21.<pub-id pub-id-type="pmid">20186856</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Gilsanz</surname><given-names>P</given-names></name><name><surname>Corrada</surname><given-names>MM</given-names></name><name><surname>Kawas</surname><given-names>CH</given-names></name><name><surname>Mayeda</surname><given-names>ER</given-names></name><name><surname>Glymour</surname><given-names>MM</given-names></name><name><surname>Quesenberry</surname><given-names>CP</given-names></name><etal/></person-group><article-title>Incidence of dementia after age 90 in a multiracial cohort</article-title><source>Alzheimers Dement</source><year>2019</year><volume>15</volume><fpage>497</fpage><lpage>505</lpage><pub-id pub-id-type="doi">10.1016/j.jalz.2018.12.006</pub-id><pub-id pub-id-type="pmid">30797730</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Gilsanz P, Corrada MM, Kawas CH, Mayeda ER, Glymour MM, Quesenberry CP, et al. Incidence of dementia after age 90 in a multiracial cohort. Alzheimers Dement. 2019;15:497&#x02013;505.<pub-id pub-id-type="pmid">30797730</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Mayeda</surname><given-names>ER</given-names></name><name><surname>Glymour</surname><given-names>MM</given-names></name><name><surname>Quesenberry</surname><given-names>CP</given-names></name><name><surname>Whitmer</surname><given-names>RA</given-names></name></person-group><article-title>Inequalities in dementia incidence between six racial and ethnic groups over 14 years</article-title><source>Physiol Behav</source><year>2016</year><volume>176</volume><fpage>100</fpage><lpage>6</lpage></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Mayeda ER, Glymour MM, Quesenberry CP, Whitmer RA. Inequalities in dementia incidence between six racial and ethnic groups over 14 years. Physiol Behav. 2016;176:100&#x02013;6.</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Matthews FE, Stephan BCM, Robinson L, Jagger C, Barnes LE, Arthur A, et al. A two decade dementia incidence comparison from the Cognitive Function and Ageing Studies I and II. Nat Commun. 2016;7:11398.</mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Wolters</surname><given-names>FJ</given-names></name><name><surname>Chibnik</surname><given-names>LB</given-names></name><name><surname>Waziry</surname><given-names>R</given-names></name><name><surname>Anderson</surname><given-names>R</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><name><surname>Beiser</surname><given-names>A</given-names></name><etal/></person-group><article-title>Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium</article-title><source>Neurology</source><year>2020</year><volume>95</volume><fpage>E519</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000010022</pub-id><pub-id pub-id-type="pmid">32611641</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Wolters FJ, Chibnik LB, Waziry R, Anderson R, Berr C, Beiser A, et al. Twenty-seven-year time trends in dementia incidence in Europe and the United States: the Alzheimer Cohorts Consortium. Neurology. 2020;95:E519&#x02013;31.<pub-id pub-id-type="pmid">32611641</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>C</given-names></name><name><surname>Hayes-Larson</surname><given-names>E</given-names></name><name><surname>Glymour</surname><given-names>MM</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Hohman</surname><given-names>TJ</given-names></name><name><surname>Whitmer</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Evaluation of selective survival and sex/gender differences in dementia incidence using a simulation model</article-title><source>JAMA Netw Open</source><year>2021</year><volume>4</volume><fpage>e211001</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.1001</pub-id><pub-id pub-id-type="pmid">33687445</pub-id>
</element-citation><mixed-citation id="mc-CR28" publication-type="journal">Shaw C, Hayes-Larson E, Glymour MM, Dufouil C, Hohman TJ, Whitmer RA, et al. Evaluation of selective survival and sex/gender differences in dementia incidence using a simulation model. JAMA Netw Open. 2021;4:e211001.<pub-id pub-id-type="pmid">33687445</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Barnes</surname><given-names>LL</given-names></name><name><surname>Wilson</surname><given-names>RS</given-names></name><name><surname>Bienias</surname><given-names>JL</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><name><surname>Evans</surname><given-names>DA</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name></person-group><article-title>Sex differences in the clinical manifestations of Alzheimer disease pathology</article-title><source>Arch Gen Psychiatry</source><year>2005</year><volume>62</volume><fpage>685</fpage><lpage>91</lpage><pub-id pub-id-type="doi">10.1001/archpsyc.62.6.685</pub-id><pub-id pub-id-type="pmid">15939846</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Barnes LL, Wilson RS, Bienias JL, Schneider JA, Evans DA, Bennett DA. Sex differences in the clinical manifestations of Alzheimer disease pathology. Arch Gen Psychiatry. 2005;62:685&#x02013;91.<pub-id pub-id-type="pmid">15939846</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Liesinger</surname><given-names>AM</given-names></name><name><surname>Graff-Radford</surname><given-names>NR</given-names></name><name><surname>Duara</surname><given-names>R</given-names></name><name><surname>Carter</surname><given-names>RE</given-names></name><name><surname>Hanna Al-Shaikh</surname><given-names>FS</given-names></name><name><surname>Koga</surname><given-names>S</given-names></name><etal/></person-group><article-title>Sex and age interact to determine clinicopathologic differences in Alzheimer&#x02019;s disease</article-title><source>Acta Neuropathol</source><year>2018</year><volume>136</volume><fpage>873</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1908-x</pub-id><pub-id pub-id-type="pmid">30219939</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Liesinger AM, Graff-Radford NR, Duara R, Carter RE, Hanna Al-Shaikh FS, Koga S, et al. Sex and age interact to determine clinicopathologic differences in Alzheimer&#x02019;s disease. Acta Neuropathol. 2018;136:873&#x02013;85.<pub-id pub-id-type="pmid">30219939</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Oveisgharan</surname><given-names>S</given-names></name><name><surname>Arvanitakis</surname><given-names>Z</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Farfel</surname><given-names>J</given-names></name><name><surname>Schneider</surname><given-names>JA</given-names></name><name><surname>Bennett</surname><given-names>DA</given-names></name></person-group><article-title>Sex differences in Alzheimer&#x02019;s disease and common neuropathologies of aging</article-title><source>Acta Neuropathol</source><year>2018</year><volume>136</volume><fpage>887</fpage><lpage>900</lpage><pub-id pub-id-type="doi">10.1007/s00401-018-1920-1</pub-id><pub-id pub-id-type="pmid">30334074</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Oveisgharan S, Arvanitakis Z, Yu L, Farfel J, Schneider JA, Bennett DA. Sex differences in Alzheimer&#x02019;s disease and common neuropathologies of aging. Acta Neuropathol. 2018;136:887&#x02013;900.<pub-id pub-id-type="pmid">30334074</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Buckley</surname><given-names>RF</given-names></name><name><surname>Mormino</surname><given-names>EC</given-names></name><name><surname>Rabin</surname><given-names>JS</given-names></name><name><surname>Hohman</surname><given-names>TJ</given-names></name><name><surname>Landau</surname><given-names>S</given-names></name><name><surname>Hanseeuw</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults</article-title><source>JAMA Neurol</source><year>2019</year><volume>76</volume><fpage>542</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2018.4693</pub-id><pub-id pub-id-type="pmid">30715078</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, et al. Sex differences in the association of global amyloid and regional tau deposition measured by positron emission tomography in clinically normal older adults. JAMA Neurol. 2019;76:542&#x02013;51.<pub-id pub-id-type="pmid">30715078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Wisch</surname><given-names>JK</given-names></name><name><surname>Meeker</surname><given-names>KL</given-names></name><name><surname>Gordon</surname><given-names>BA</given-names></name><name><surname>Flores</surname><given-names>S</given-names></name><name><surname>Dincer</surname><given-names>A</given-names></name><name><surname>Grant</surname><given-names>EA</given-names></name><etal/></person-group><article-title>Sex-related differences in tau positron emission tomography (PET) and the effects of hormone therapy (HT)</article-title><source>Alzheimer Dis Assoc Disord</source><year>2021</year><volume>35</volume><fpage>164</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1097/WAD.0000000000000393</pub-id><pub-id pub-id-type="pmid">32520734</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Wisch JK, Meeker KL, Gordon BA, Flores S, Dincer A, Grant EA, et al. Sex-related differences in tau positron emission tomography (PET) and the effects of hormone therapy (HT). Alzheimer Dis Assoc Disord. 2021;35:164&#x02013;8.<pub-id pub-id-type="pmid">32520734</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>JB</given-names></name><name><surname>Harrison</surname><given-names>TM</given-names></name><name><surname>La Joie</surname><given-names>R</given-names></name><name><surname>Baker</surname><given-names>SL</given-names></name><name><surname>Jagust</surname><given-names>WJ</given-names></name></person-group><article-title>Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults</article-title><source>Eur J Nucl Med Mol Imaging</source><year>2020</year><volume>47</volume><fpage>2155</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1007/s00259-019-04669-x</pub-id><pub-id pub-id-type="pmid">31915896</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. Eur J Nucl Med Mol Imaging. 2020;47:2155&#x02013;64.<pub-id pub-id-type="pmid">31915896</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>Edwards</surname><given-names>L</given-names></name><name><surname>La Joie</surname><given-names>R</given-names></name><name><surname>Iaccarino</surname><given-names>L</given-names></name><name><surname>Strom</surname><given-names>A</given-names></name><name><surname>Baker</surname><given-names>SL</given-names></name><name><surname>Casaletto</surname><given-names>KB</given-names></name><etal/></person-group><article-title>Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer&#x02019;s continuum: greater tau-PET retention in females</article-title><source>Neurobiol Aging</source><year>2021</year><volume>105</volume><fpage>86</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2021.04.003</pub-id><pub-id pub-id-type="pmid">34049062</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">Edwards L, La Joie R, Iaccarino L, Strom A, Baker SL, Casaletto KB, et al. Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer&#x02019;s continuum: greater tau-PET retention in females. Neurobiol Aging. 2021;105:86&#x02013;98.<pub-id pub-id-type="pmid">34049062</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Filon</surname><given-names>JR</given-names></name><name><surname>Intorcia</surname><given-names>AJ</given-names></name><name><surname>Sue</surname><given-names>LI</given-names></name><name><surname>Vazquez Arreola</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>J</given-names></name><name><surname>Davis</surname><given-names>KJ</given-names></name><etal/></person-group><article-title>Gender differences in Alzheimer disease: brain atrophy, histopathology burden, and cognition</article-title><source>J Neuropathol Exp Neurol</source><year>2016</year><volume>75</volume><fpage>748</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1093/jnen/nlw047</pub-id><pub-id pub-id-type="pmid">27297671</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, et al. Gender differences in Alzheimer disease: brain atrophy, histopathology burden, and cognition. J Neuropathol Exp Neurol. 2016;75:748&#x02013;54.<pub-id pub-id-type="pmid">27297671</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Babapour Mofrad</surname><given-names>R</given-names></name><name><surname>Tijms</surname><given-names>BM</given-names></name><name><surname>Scheltens</surname><given-names>P</given-names></name><name><surname>Barkhof</surname><given-names>F</given-names></name><name><surname>Van Der Flier</surname><given-names>WM</given-names></name><name><surname>Sikkes</surname><given-names>SAM</given-names></name><etal/></person-group><article-title>Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE &#x003f5;4 genotype</article-title><source>Neurology.</source><year>2020</year><volume>95</volume><fpage>e2378</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000010629</pub-id><pub-id pub-id-type="pmid">32788242</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Babapour Mofrad R, Tijms BM, Scheltens P, Barkhof F, Van Der Flier WM, Sikkes SAM, et al. Sex differences in CSF biomarkers vary by Alzheimer disease stage and APOE &#x003f5;4 genotype. Neurology. 2020;95:e2378&#x02013;88.<pub-id pub-id-type="pmid">32788242</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Hohman</surname><given-names>TJ</given-names></name><name><surname>Dumitrescu</surname><given-names>L</given-names></name><name><surname>Barnes</surname><given-names>LL</given-names></name><name><surname>Thambisetty</surname><given-names>M</given-names></name><name><surname>Beecham</surname><given-names>G</given-names></name><name><surname>Kunkle</surname><given-names>B</given-names></name><etal/></person-group><article-title>Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau</article-title><source>JAMA Neurol</source><year>2018</year><volume>75</volume><fpage>989</fpage><lpage>98</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2018.0821</pub-id><pub-id pub-id-type="pmid">29801024</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Hohman TJ, Dumitrescu L, Barnes LL, Thambisetty M, Beecham G, Kunkle B, et al. Sex-specific association of apolipoprotein E with cerebrospinal fluid levels of tau. JAMA Neurol. 2018;75:989&#x02013;98.<pub-id pub-id-type="pmid">29801024</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>DA</given-names></name><name><surname>Gross</surname><given-names>AL</given-names></name><name><surname>Brice&#x000f1;o</surname><given-names>EM</given-names></name><name><surname>Tilton</surname><given-names>N</given-names></name><name><surname>Giordani</surname><given-names>BJ</given-names></name><name><surname>Sussman</surname><given-names>JB</given-names></name><etal/></person-group><article-title>Sex differences in cognitive decline among US adults</article-title><source>JAMA Netw Open</source><year>2021</year><volume>4</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2021.0169</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Levine DA, Gross AL, Brice&#x000f1;o EM, Tilton N, Giordani BJ, Sussman JB, et al. Sex differences in cognitive decline among US adults. JAMA Netw Open. 2021;4:1&#x02013;13.</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Bloomberg</surname><given-names>M</given-names></name><name><surname>Dugravot</surname><given-names>A</given-names></name><name><surname>Dumurgier</surname><given-names>J</given-names></name><name><surname>Kivimaki</surname><given-names>M</given-names></name><name><surname>Fayosse</surname><given-names>A</given-names></name><name><surname>Steptoe</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sex differences and the role of education in cognitive ageing: analysis of two UK-based prospective cohort studies</article-title><source>Lancet Public Health</source><year>2021</year><volume>6</volume><fpage>e106</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1016/S2468-2667(20)30258-9</pub-id><pub-id pub-id-type="pmid">33516287</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Bloomberg M, Dugravot A, Dumurgier J, Kivimaki M, Fayosse A, Steptoe A, et al. Sex differences and the role of education in cognitive ageing: analysis of two UK-based prospective cohort studies. Lancet Public Health. 2021;6:e106&#x02013;15.<pub-id pub-id-type="pmid">33516287</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Lipnicki</surname><given-names>DM</given-names></name><name><surname>Crawford</surname><given-names>JD</given-names></name><name><surname>Dutta</surname><given-names>R</given-names></name><name><surname>Thalamuthu</surname><given-names>A</given-names></name><name><surname>Kochan</surname><given-names>NA</given-names></name><name><surname>Andrews</surname><given-names>G</given-names></name><etal/></person-group><article-title>Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study</article-title><source>PLoS Med</source><year>2017</year><volume>14</volume><fpage>1</fpage><lpage>21</lpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1002261</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Lipnicki DM, Crawford JD, Dutta R, Thalamuthu A, Kochan NA, Andrews G, et al. Age-related cognitive decline and associations with sex, education and apolipoprotein E genotype across ethnocultural groups and geographic regions: a collaborative cohort study. PLoS Med. 2017;14:1&#x02013;21.</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>MT</given-names></name><name><surname>Iulita</surname><given-names>MF</given-names></name><name><surname>Cavedo</surname><given-names>E</given-names></name><name><surname>Chiesa</surname><given-names>PA</given-names></name><name><surname>Dimech</surname><given-names>AS</given-names></name><name><surname>Chadha</surname><given-names>AS</given-names></name><etal/></person-group><article-title>Sex differences in Alzheimer disease&#x02014;the gateway to precision medicine</article-title><source>Nat Rev Neurol</source><year>2018</year><volume>14</volume><fpage>457</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1038/s41582-018-0032-9</pub-id><pub-id pub-id-type="pmid">29985474</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Dimech AS, Chadha AS, et al. Sex differences in Alzheimer disease&#x02014;the gateway to precision medicine. Nat Rev Neurol. 2018;14:457&#x02013;69.<pub-id pub-id-type="pmid">29985474</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Arenaza-Urquijo</surname><given-names>EM</given-names></name><name><surname>Boyle</surname><given-names>R</given-names></name><name><surname>Casaletto</surname><given-names>K</given-names></name><name><surname>Anstey</surname><given-names>KJ</given-names></name><name><surname>Vila-Castelar</surname><given-names>C</given-names></name><name><surname>Colverson</surname><given-names>A</given-names></name><etal/></person-group><article-title>Sex and gender differences in cognitive resilience to aging and Alzheimer&#x02019;s disease</article-title><source>Alzheimers Dement</source><year>2024</year><volume>20</volume><fpage>5695</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1002/alz.13844</pub-id><pub-id pub-id-type="pmid">38967222</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Arenaza-Urquijo EM, Boyle R, Casaletto K, Anstey KJ, Vila-Castelar C, Colverson A, et al. Sex and gender differences in cognitive resilience to aging and Alzheimer&#x02019;s disease. Alzheimers Dement. 2024;20:5695&#x02013;719.<pub-id pub-id-type="pmid">38967222</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Ferretti</surname><given-names>MT</given-names></name><name><surname>Martinkova</surname><given-names>J</given-names></name><name><surname>Biskup</surname><given-names>E</given-names></name><name><surname>Benke</surname><given-names>T</given-names></name><name><surname>Gialdini</surname><given-names>G</given-names></name><name><surname>Nedelska</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Sex and gender differences in Alzheimer&#x02019;s disease: current challenges and implications for clinical practice: position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology</article-title><source>Eur J Neurol</source><year>2020</year><volume>27</volume><fpage>928</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1111/ene.14174</pub-id><pub-id pub-id-type="pmid">32056347</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Ferretti MT, Martinkova J, Biskup E, Benke T, Gialdini G, Nedelska Z, et al. Sex and gender differences in Alzheimer&#x02019;s disease: current challenges and implications for clinical practice: position paper of the Dementia and Cognitive Disorders Panel of the European Academy of Neurology. Eur J Neurol. 2020;27:928&#x02013;43.<pub-id pub-id-type="pmid">32056347</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Tifratene</surname><given-names>K</given-names></name><name><surname>Robert</surname><given-names>P</given-names></name><name><surname>Metelkina</surname><given-names>A</given-names></name><name><surname>Pradier</surname><given-names>C</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name></person-group><article-title>Progression of mild cognitive impairment to dementia due to AD in clinical settings</article-title><source>Neurology</source><year>2015</year><volume>85</volume><fpage>331</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000001788</pub-id><pub-id pub-id-type="pmid">26136516</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Tifratene K, Robert P, Metelkina A, Pradier C, Dartigues JF. Progression of mild cognitive impairment to dementia due to AD in clinical settings. Neurology. 2015;85:331&#x02013;8.<pub-id pub-id-type="pmid">26136516</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>KA</given-names></name><name><surname>Choudhury</surname><given-names>KR</given-names></name><name><surname>Rathakrishnan</surname><given-names>BG</given-names></name><name><surname>Marks</surname><given-names>DM</given-names></name><name><surname>Petrella</surname><given-names>JR</given-names></name><name><surname>Doraiswamy</surname><given-names>PM</given-names></name></person-group><article-title>Marked gender differences in progression of mild cognitive impairment over 8 years</article-title><source>Alzheimers Dement Transl Res Clin Interv</source><year>2015</year><volume>1</volume><fpage>103</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.1016/j.trci.2015.07.001</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM. Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimers Dement Transl Res Clin Interv. 2015;1:103&#x02013;10.</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>EJ</given-names></name><name><surname>Broestl</surname><given-names>L</given-names></name><name><surname>Williams</surname><given-names>G</given-names></name><name><surname>Garay</surname><given-names>BI</given-names></name><name><surname>Lobach</surname><given-names>I</given-names></name><name><surname>Devidze</surname><given-names>N</given-names></name><etal/></person-group><article-title>A second X chromosome contributes to resilience in a mouse model of Alzheimer&#x02019;s disease</article-title><source>Sci Transl Med</source><year>2020</year><volume>12</volume><fpage>eaaz5677</fpage><pub-id pub-id-type="doi">10.1126/scitranslmed.aaz5677</pub-id><pub-id pub-id-type="pmid">32848093</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Davis EJ, Broestl L, Williams G, Garay BI, Lobach I, Devidze N, et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer&#x02019;s disease. Sci Transl Med. 2020;12:eaaz5677.<pub-id pub-id-type="pmid">32848093</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Shang</surname><given-names>H</given-names></name></person-group><article-title>Predictors for survival in patients with Alzheimer&#x02019;s disease: a large comprehensive meta-analysis</article-title><source>Transl Psychiatry</source><year>2024</year><volume>14</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41398-024-02897-w</pub-id><pub-id pub-id-type="pmid">38172115</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Zheng X, Wang S, Huang J, Li C, Shang H. Predictors for survival in patients with Alzheimer&#x02019;s disease: a large comprehensive meta-analysis. Transl Psychiatry. 2024;14:1&#x02013;9.<pub-id pub-id-type="pmid">38172115</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>EJ</given-names></name><name><surname>Solsberg</surname><given-names>CW</given-names></name><name><surname>White</surname><given-names>CC</given-names></name><name><surname>Mi&#x000f1;ones-Moyano</surname><given-names>E</given-names></name><name><surname>Sirota</surname><given-names>M</given-names></name><name><surname>Chibnik</surname><given-names>L</given-names></name><etal/></person-group><article-title>Sex-specific association of the X chromosome with cognitive change and tau pathology in aging and Alzheimer disease</article-title><source>JAMA Neurol</source><year>2021</year><volume>78</volume><fpage>1249</fpage><lpage>54</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2021.2806</pub-id><pub-id pub-id-type="pmid">34424272</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Davis EJ, Solsberg CW, White CC, Mi&#x000f1;ones-Moyano E, Sirota M, Chibnik L, et al. Sex-specific association of the X chromosome with cognitive change and tau pathology in aging and Alzheimer disease. JAMA Neurol. 2021;78:1249&#x02013;54.<pub-id pub-id-type="pmid">34424272</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><mixed-citation publication-type="other">Yan Y, Wang X, Chaput D, Pieper AA, Woo JA, Kang DE, et al. X-linked ubiquitin-specific peptidase 11 increases tauopathy vulnerability in women increases tauopathy vulnerability in women. Cell. 2022;185:3913&#x02013;30.e19.</mixed-citation></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>JZ</given-names></name><name><surname>Erlich</surname><given-names>Y</given-names></name><name><surname>Pickrell</surname><given-names>JK</given-names></name></person-group><article-title>Case-control association mapping by proxy using family history of disease</article-title><source>Nat Genet</source><year>2017</year><volume>49</volume><fpage>325</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1038/ng.3766</pub-id><pub-id pub-id-type="pmid">28092683</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Liu JZ, Erlich Y, Pickrell JK. Case-control association mapping by proxy using family history of disease. Nat Genet. 2017;49:325&#x02013;31.<pub-id pub-id-type="pmid">28092683</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>IE</given-names></name><name><surname>van der Lee</surname><given-names>SJ</given-names></name><name><surname>Gomez-Fonseca</surname><given-names>D</given-names></name><name><surname>de Rojas</surname><given-names>I</given-names></name><name><surname>Dalmasso</surname><given-names>MC</given-names></name><name><surname>Grenier-Boley</surname><given-names>B</given-names></name><etal/></person-group><article-title>Genome-wide meta-analysis for Alzheimer&#x02019;s disease cerebrospinal fluid biomarkers</article-title><source>Acta Neuropathol</source><year>2022</year><volume>144</volume><fpage>821</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1007/s00401-022-02454-z</pub-id><pub-id pub-id-type="pmid">36066633</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Jansen IE, van der Lee SJ, Gomez-Fonseca D, de Rojas I, Dalmasso MC, Grenier-Boley B, et al. Genome-wide meta-analysis for Alzheimer&#x02019;s disease cerebrospinal fluid biomarkers. Acta Neuropathol. 2022;144:821&#x02013;42.<pub-id pub-id-type="pmid">36066633</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Luck</surname><given-names>T</given-names></name><name><surname>Riedel-Heller</surname><given-names>SG</given-names></name><name><surname>Kaduszkiewicz</surname><given-names>H</given-names></name><name><surname>Bickel</surname><given-names>H</given-names></name><name><surname>Jessen</surname><given-names>F</given-names></name><name><surname>Pentzek</surname><given-names>M</given-names></name><etal/></person-group><article-title>Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe)</article-title><source>Dement Geriatr Cogn Disord</source><year>2007</year><volume>24</volume><fpage>307</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1159/000108099</pub-id><pub-id pub-id-type="pmid">17848793</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Luck T, Riedel-Heller SG, Kaduszkiewicz H, Bickel H, Jessen F, Pentzek M, et al. Mild cognitive impairment in general practice: age-specific prevalence and correlate results from the German study on ageing, cognition and dementia in primary care patients (AgeCoDe). Dement Geriatr Cogn Disord. 2007;24:307&#x02013;16.<pub-id pub-id-type="pmid">17848793</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Grande</surname><given-names>G</given-names></name><name><surname>Vetrano</surname><given-names>DL</given-names></name><name><surname>Fratiglioni</surname><given-names>L</given-names></name><name><surname>Marseglia</surname><given-names>A</given-names></name><name><surname>Vanacore</surname><given-names>N</given-names></name><name><surname>Laukka</surname><given-names>EJ</given-names></name><etal/></person-group><article-title>Disability trajectories and mortality in older adults with different cognitive and physical profiles</article-title><source>Aging Clin Exp Res</source><year>2020</year><volume>32</volume><fpage>1007</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1007/s40520-019-01297-1</pub-id><pub-id pub-id-type="pmid">31471890</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Grande G, Vetrano DL, Fratiglioni L, Marseglia A, Vanacore N, Laukka EJ, et al. Disability trajectories and mortality in older adults with different cognitive and physical profiles. Aging Clin Exp Res. 2020;32:1007&#x02013;16.<pub-id pub-id-type="pmid">31471890</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Artero</surname><given-names>S</given-names></name><name><surname>Ancelin</surname><given-names>ML</given-names></name><name><surname>Portet</surname><given-names>F</given-names></name><name><surname>Dupuy</surname><given-names>A</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Risk profiles for mild cognitive impairment and progression to dementia are gender specific</article-title><source>J Neurol Neurosurg Psychiatry</source><year>2008</year><volume>79</volume><fpage>979</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1136/jnnp.2007.136903</pub-id><pub-id pub-id-type="pmid">18450788</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Artero S, Ancelin ML, Portet F, Dupuy A, Berr C, Dartigues JF, et al. Risk profiles for mild cognitive impairment and progression to dementia are gender specific. J Neurol Neurosurg Psychiatry. 2008;79:979&#x02013;84.<pub-id pub-id-type="pmid">18450788</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><mixed-citation publication-type="other">Kurki MI, Karjalainen J, Palta P, Sipil&#x000e4; TP, Kristiansson K. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023:613;508&#x02013;18.</mixed-citation></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Taliun</surname><given-names>D</given-names></name><name><surname>Harris</surname><given-names>DN</given-names></name><name><surname>Kessler</surname><given-names>MD</given-names></name><name><surname>Carlson</surname><given-names>J</given-names></name><name><surname>Szpiech</surname><given-names>ZA</given-names></name><name><surname>Torres</surname><given-names>R</given-names></name><etal/></person-group><article-title>Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program</article-title><source>Nature</source><year>2021</year><volume>590</volume><fpage>290</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41586-021-03205-y</pub-id><pub-id pub-id-type="pmid">33568819</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Taliun D, Harris DN, Kessler MD, Carlson J, Szpiech ZA, Torres R, et al. Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program. Nature. 2021;590:290&#x02013;9.<pub-id pub-id-type="pmid">33568819</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Auton</surname><given-names>A</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name><name><surname>Altshuler</surname><given-names>DM</given-names></name><name><surname>Durbin</surname><given-names>RM</given-names></name><name><surname>Bentley</surname><given-names>DR</given-names></name><name><surname>Chakravarti</surname><given-names>A</given-names></name><etal/></person-group><article-title>A global reference for human genetic variation</article-title><source>Nature</source><year>2015</year><volume>526</volume><fpage>68</fpage><lpage>74</lpage><pub-id pub-id-type="doi">10.1038/nature15393</pub-id><pub-id pub-id-type="pmid">26432245</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Auton A, Abecasis GR, Altshuler DM, Durbin RM, Bentley DR, Chakravarti A, et al. A global reference for human genetic variation. Nature. 2015;526:68&#x02013;74.<pub-id pub-id-type="pmid">26432245</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Loh</surname><given-names>PR</given-names></name><name><surname>Danecek</surname><given-names>P</given-names></name><name><surname>Palamara</surname><given-names>PF</given-names></name><name><surname>Fuchsberger</surname><given-names>C</given-names></name><name><surname>Reshef</surname><given-names>YA</given-names></name><name><surname>Finucane</surname><given-names>HK</given-names></name><etal/></person-group><article-title>Reference-based phasing using the Haplotype Reference Consortium panel</article-title><source>Nat Genet</source><year>2016</year><volume>48</volume><fpage>1443</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.1038/ng.3679</pub-id><pub-id pub-id-type="pmid">27694958</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Loh PR, Danecek P, Palamara PF, Fuchsberger C, Reshef YA, Finucane HK, et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat Genet. 2016;48:1443&#x02013;8.<pub-id pub-id-type="pmid">27694958</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Walter</surname><given-names>K</given-names></name><name><surname>Min</surname><given-names>JL</given-names></name><name><surname>Huang</surname><given-names>J</given-names></name><name><surname>Crooks</surname><given-names>L</given-names></name><name><surname>Memari</surname><given-names>Y</given-names></name><name><surname>McCarthy</surname><given-names>S</given-names></name><etal/></person-group><article-title>The UK10K project identifies rare variants in health and disease</article-title><source>Nature</source><year>2015</year><volume>526</volume><fpage>82</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1038/nature14962</pub-id><pub-id pub-id-type="pmid">26367797</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Walter K, Min JL, Huang J, Crooks L, Memari Y, McCarthy S, et al. The UK10K project identifies rare variants in health and disease. Nature. 2015;526:82&#x02013;89.<pub-id pub-id-type="pmid">26367797</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>DG</given-names></name></person-group><article-title>Sex chromosomes and genetic association studies</article-title><source>Genome Med</source><year>2009</year><volume>1</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1186/gm110</pub-id><pub-id pub-id-type="pmid">19348688</pub-id>
</element-citation><mixed-citation id="mc-CR61" publication-type="journal">Clayton DG. Sex chromosomes and genetic association studies. Genome Med. 2009;1:1&#x02013;7.<pub-id pub-id-type="pmid">19348688</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Clayton</surname><given-names>DG</given-names></name></person-group><article-title>Testing for association on the X chromosome</article-title><source>Biostatistics</source><year>2008</year><volume>9</volume><fpage>593</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1093/biostatistics/kxn007</pub-id><pub-id pub-id-type="pmid">18441336</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Clayton DG. Testing for association on the X chromosome. Biostatistics. 2008;9:593&#x02013;600.<pub-id pub-id-type="pmid">18441336</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>A</given-names></name><name><surname>Hartge</surname><given-names>P</given-names></name><name><surname>Kraft</surname><given-names>P</given-names></name><name><surname>Joshi</surname><given-names>AD</given-names></name><name><surname>Ziegler</surname><given-names>RG</given-names></name><name><surname>Chanock</surname><given-names>SJ</given-names></name><etal/></person-group><article-title>Leveraging family history in population-based case-control association studies</article-title><source>Genet Epidemiol</source><year>2014</year><volume>38</volume><fpage>114</fpage><lpage>22</lpage><pub-id pub-id-type="doi">10.1002/gepi.21785</pub-id><pub-id pub-id-type="pmid">24408355</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Ghosh A, Hartge P, Kraft P, Joshi AD, Ziegler RG, Chanock SJ, et al. Leveraging family history in population-based case-control association studies. Genet Epidemiol. 2014;38:114&#x02013;22.<pub-id pub-id-type="pmid">24408355</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Willer</surname><given-names>CJ</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Abecasis</surname><given-names>GR</given-names></name></person-group><article-title>METAL: fast and efficient meta-analysis of genomewide association scans</article-title><source>Bioinformatics</source><year>2010</year><volume>26</volume><fpage>2190</fpage><lpage>1</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq340</pub-id><pub-id pub-id-type="pmid">20616382</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x02013;1.<pub-id pub-id-type="pmid">20616382</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Magi</surname><given-names>R</given-names></name><name><surname>Lindgren</surname><given-names>CM</given-names></name><name><surname>Morris</surname><given-names>AP</given-names></name></person-group><article-title>Meta-analysis of sex-specific genome-wide association studies</article-title><source>Genet Epidemiol</source><year>2010</year><volume>34</volume><fpage>846</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1002/gepi.20540</pub-id><pub-id pub-id-type="pmid">21104887</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Magi R, Lindgren CM, Morris AP. Meta-analysis of sex-specific genome-wide association studies. Genet Epidemiol. 2010;34:846&#x02013;53.<pub-id pub-id-type="pmid">21104887</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Satizabal</surname><given-names>CL</given-names></name><name><surname>Adams</surname><given-names>HH</given-names></name><name><surname>Hibar</surname><given-names>DP</given-names></name><name><surname>White</surname><given-names>CC</given-names></name></person-group><article-title>Genetic architecture of subcortical brain structures in 38,851 individuals</article-title><source>Physiol Behav</source><year>2019</year><volume>176</volume><fpage>139</fpage><lpage>48</lpage></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Satizabal CL, Adams HH, Hibar DP, White CC. Genetic architecture of subcortical brain structures in 38,851 individuals. Physiol Behav. 2019;176:139&#x02013;48.</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Aulchenko</surname><given-names>YS</given-names></name><name><surname>Ripke</surname><given-names>S</given-names></name><name><surname>Isaacs</surname><given-names>A</given-names></name><name><surname>van Duijn</surname><given-names>CM</given-names></name></person-group><article-title>GenABEL: an R library for genome-wide association analysis</article-title><source>Bioinformatics</source><year>2007</year><volume>23</volume><fpage>1294</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btm108</pub-id><pub-id pub-id-type="pmid">17384015</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R library for genome-wide association analysis. Bioinformatics. 2007;23:1294&#x02013;6.<pub-id pub-id-type="pmid">17384015</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Marchini</surname><given-names>J</given-names></name><name><surname>Howie</surname><given-names>B</given-names></name><name><surname>Myers</surname><given-names>S</given-names></name><name><surname>McVean</surname><given-names>G</given-names></name><name><surname>Donnelly</surname><given-names>P</given-names></name></person-group><article-title>A new multipoint method for genome-wide association studies by imputation of genotypes</article-title><source>Nat Genet</source><year>2007</year><volume>39</volume><fpage>906</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/ng2088</pub-id><pub-id pub-id-type="pmid">17572673</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Marchini J, Howie B, Myers S, McVean G, Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet. 2007;39:906&#x02013;13.<pub-id pub-id-type="pmid">17572673</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Philipps</surname><given-names>V</given-names></name><name><surname>Amieva</surname><given-names>H</given-names></name><name><surname>Andrieu</surname><given-names>S</given-names></name><name><surname>Dufouil</surname><given-names>C</given-names></name><name><surname>Berr</surname><given-names>C</given-names></name><name><surname>Dartigues</surname><given-names>JF</given-names></name><etal/></person-group><article-title>Normalized mini-mental state examination for assessing cognitive change in population-based brain aging studies</article-title><source>Neuroepidemiology</source><year>2014</year><volume>43</volume><fpage>15</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1159/000365637</pub-id><pub-id pub-id-type="pmid">25248074</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Philipps V, Amieva H, Andrieu S, Dufouil C, Berr C, Dartigues JF, et al. Normalized mini-mental state examination for assessing cognitive change in population-based brain aging studies. Neuroepidemiology. 2014;43:15&#x02013;25.<pub-id pub-id-type="pmid">25248074</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Kleineidam</surname><given-names>L</given-names></name><name><surname>Chouraki</surname><given-names>V</given-names></name><name><surname>Pr&#x000f3;chnicki</surname><given-names>T</given-names></name><name><surname>van der Lee</surname><given-names>SJ</given-names></name><name><surname>Madrid-M&#x000e1;rquez</surname><given-names>L</given-names></name><name><surname>Wagner-Thelen</surname><given-names>H</given-names></name><etal/></person-group><article-title>PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment</article-title><source>Acta Neuropathol</source><year>2020</year><volume>139</volume><fpage>1025</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1007/s00401-020-02138-6</pub-id><pub-id pub-id-type="pmid">32166339</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Kleineidam L, Chouraki V, Pr&#x000f3;chnicki T, van der Lee SJ, Madrid-M&#x000e1;rquez L, Wagner-Thelen H, et al. PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment. Acta Neuropathol. 2020;139:1025&#x02013;44.<pub-id pub-id-type="pmid">32166339</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><mixed-citation publication-type="other">Wingo AP, Liu Y, Gerasimov ES, Vattathil SM, Liu J, Cutler DJ, et al. Sex differences in brain protein expression and disease. Nat Med. 2023;29:2224&#x02013;32.</mixed-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Lukacsovich D, O&#x02019;Shea D, Huang H, Zhang W, Youn JI, Chen XS, et al. MIAMI-AD (methylation in aging and methylation in AD): an integrative knowledgebase that facilitates explorations of DNA methylation across sex, aging, and Alzheimer&#x02019;s disease. MedRxiv. 2023.</mixed-citation></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>de Leeuw</surname><given-names>CA</given-names></name><name><surname>Mooij</surname><given-names>JM</given-names></name><name><surname>Heskes</surname><given-names>T</given-names></name><name><surname>Posthuma</surname><given-names>D</given-names></name></person-group><article-title>MAGMA: generalized gene-set analysis of GWAS data</article-title><source>PLoS Comput Biol</source><year>2015</year><volume>11</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1371/journal.pcbi.1004219</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:1&#x02013;19.</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Cappellini MD, Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet. 2008;371:64&#x02013;74.</mixed-citation></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Group</surname><given-names>WW</given-names></name></person-group><article-title>Glucose-6-phosphate dehydrogenase deficiency</article-title><source>Bull World Health Organ</source><year>1989</year><volume>67</volume><fpage>601</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">2633878</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Group WW. Glucose-6-phosphate dehydrogenase deficiency. Bull World Health Organ. 1989;67:601&#x02013;11.<pub-id pub-id-type="pmid">2633878</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>HW</given-names></name><name><surname>Jeonghoon</surname><given-names>C</given-names></name><name><surname>Hyewon</surname><given-names>S</given-names></name><name><surname>Karam</surname><given-names>K</given-names></name><name><surname>Jinhee</surname><given-names>Y</given-names></name><name><surname>Moonseok</surname><given-names>N</given-names></name><etal/></person-group><article-title>Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis</article-title><source>J Neurosci</source><year>2008</year><volume>28</volume><fpage>14546</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.3112-08.2008</pub-id><pub-id pub-id-type="pmid">19118189</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Lee HW, Jeonghoon C, Hyewon S, Karam K, Jinhee Y, Moonseok N, et al. Preso, a novel PSD-95-interacting FERM and PDZ domain protein that regulates dendritic spine morphogenesis. J Neurosci. 2008;28:14546&#x02013;56.<pub-id pub-id-type="pmid">19118189</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Piard</surname><given-names>J</given-names></name><name><surname>Hu</surname><given-names>JH</given-names></name><name><surname>Campeau</surname><given-names>PM</given-names></name><name><surname>Rzo&#x00144;ca</surname><given-names>S</given-names></name><name><surname>Van Esch</surname><given-names>H</given-names></name><name><surname>Vincent</surname><given-names>E</given-names></name><etal/></person-group><article-title>FRMPD4 mutations cause X-linked intellectual disability and disrupt dendritic spine morphogenesis</article-title><source>Hum Mol Genet</source><year>2018</year><volume>27</volume><fpage>589</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1093/hmg/ddx426</pub-id><pub-id pub-id-type="pmid">29267967</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Piard J, Hu JH, Campeau PM, Rzo&#x00144;ca S, Van Esch H, Vincent E, et al. FRMPD4 mutations cause X-linked intellectual disability and disrupt dendritic spine morphogenesis. Hum Mol Genet. 2018;27:589&#x02013;600.<pub-id pub-id-type="pmid">29267967</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Okbay</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>N</given-names></name><name><surname>Jayashankar</surname><given-names>H</given-names></name><name><surname>Bennett</surname><given-names>M</given-names></name><name><surname>Nehzati</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals</article-title><source>Nat Genet</source><year>2022</year><volume>54</volume><fpage>437</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1038/s41588-022-01016-z</pub-id><pub-id pub-id-type="pmid">35361970</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Okbay A, Wu Y, Wang N, Jayashankar H, Bennett M, Nehzati SM, et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nat Genet. 2022;54:437&#x02013;49.<pub-id pub-id-type="pmid">35361970</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Jansen</surname><given-names>IE</given-names></name><name><surname>Savage</surname><given-names>JE</given-names></name><name><surname>Watanabe</surname><given-names>K</given-names></name><name><surname>Bryois</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>DM</given-names></name><name><surname>Steinberg</surname><given-names>S</given-names></name><etal/></person-group><article-title>Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x02019;s disease risk</article-title><source>Nat Genet</source><year>2019</year><volume>51</volume><fpage>404</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/s41588-018-0311-9</pub-id><pub-id pub-id-type="pmid">30617256</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S, et al. Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer&#x02019;s disease risk. Nat Genet. 2019;51:404&#x02013;13.<pub-id pub-id-type="pmid">30617256</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>ER</given-names></name><name><surname>Cayrou</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>R</given-names></name><name><surname>Lane</surname><given-names>WS</given-names></name><name><surname>C&#x000f4;t&#x000e9;</surname><given-names>J</given-names></name><name><surname>Lucchesi</surname><given-names>JC</given-names></name></person-group><article-title>A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16</article-title><source>Mol Cell Biol</source><year>2005</year><volume>25</volume><fpage>9175</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1128/MCB.25.21.9175-9188.2005</pub-id><pub-id pub-id-type="pmid">16227571</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Smith ER, Cayrou C, Huang R, Lane WS, C&#x000f4;t&#x000e9; J, Lucchesi JC. A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16. Mol Cell Biol. 2005;25:9175&#x02013;88.<pub-id pub-id-type="pmid">16227571</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Hayward</surname><given-names>GC</given-names></name><name><surname>Caceres</surname><given-names>D</given-names></name><name><surname>Copeland</surname><given-names>EN</given-names></name><name><surname>Baranowski</surname><given-names>BJ</given-names></name><name><surname>Mohammad</surname><given-names>A</given-names></name><name><surname>Whitley</surname><given-names>KC</given-names></name><etal/></person-group><article-title>Characterization of Alzheimer&#x02019;s disease-like neuropathology in Duchenne&#x02019;s muscular dystrophy using the DBA/2J mdx mouse model</article-title><source>FEBS Open Bio</source><year>2022</year><volume>12</volume><fpage>154</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1002/2211-5463.13317</pub-id><pub-id pub-id-type="pmid">34668666</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Hayward GC, Caceres D, Copeland EN, Baranowski BJ, Mohammad A, Whitley KC, et al. Characterization of Alzheimer&#x02019;s disease-like neuropathology in Duchenne&#x02019;s muscular dystrophy using the DBA/2J mdx mouse model. FEBS Open Bio. 2022;12:154&#x02013;62.<pub-id pub-id-type="pmid">34668666</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>K-W</given-names></name><name><surname>Yuan</surname><given-names>Y-X</given-names></name><name><surname>Zhu</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>Y-F</given-names></name><name><surname>Meng</surname><given-names>F-S</given-names></name><etal/></person-group><article-title>X chromosome-wide association study of quantitative biomarkers from the Alzheimer&#x02019;s Disease Neuroimaging Initiative study</article-title><source>Front Aging Neurosci</source><year>2023</year><volume>15</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.3389/fnagi.2023.1277731</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Wang K-W, Yuan Y-X, Zhu B, Zhang Y, Wei Y-F, Meng F-S, et al. X chromosome-wide association study of quantitative biomarkers from the Alzheimer&#x02019;s Disease Neuroimaging Initiative study. Front Aging Neurosci. 2023;15:1&#x02013;15.</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Begum</surname><given-names>G</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Kahle</surname><given-names>KT</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Shi</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inhibition of WNK3 kinase signaling reduces brain damage and accelerates neurological recovery after stroke</article-title><source>Stroke.</source><year>2015</year><volume>46</volume><fpage>1956</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.115.008939</pub-id><pub-id pub-id-type="pmid">26069258</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Begum G, Yuan H, Kahle KT, Li L, Wang S, Shi Y, et al. Inhibition of WNK3 kinase signaling reduces brain damage and accelerates neurological recovery after stroke. Stroke. 2015;46:1956&#x02013;65.<pub-id pub-id-type="pmid">26069258</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Lai</surname><given-names>N</given-names></name><name><surname>Deng</surname><given-names>R</given-names></name><name><surname>Liang</surname><given-names>T</given-names></name><name><surname>Pan</surname><given-names>P</given-names></name><name><surname>Yuan</surname><given-names>G</given-names></name><etal/></person-group><article-title>Activated WNK3 induced by intracerebral hemorrhage deteriorates brain injury maybe via WNK3/SPAK/NKCC1 pathway</article-title><source>Exp Neurol</source><year>2020</year><volume>332</volume><fpage>113386</fpage><pub-id pub-id-type="doi">10.1016/j.expneurol.2020.113386</pub-id><pub-id pub-id-type="pmid">32589890</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Wu D, Lai N, Deng R, Liang T, Pan P, Yuan G, et al. Activated WNK3 induced by intracerebral hemorrhage deteriorates brain injury maybe via WNK3/SPAK/NKCC1 pathway. Exp Neurol. 2020;332:113386.<pub-id pub-id-type="pmid">32589890</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Tan</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><etal/></person-group><article-title>WNK3 promotes neuronal survival after traumatic brain injury in rats</article-title><source>Neuroscience</source><year>2021</year><volume>477</volume><fpage>76</fpage><lpage>88</lpage><pub-id pub-id-type="doi">10.1016/j.neuroscience.2021.09.021</pub-id><pub-id pub-id-type="pmid">34626749</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Zhu J, Lin X, Chen C, Tan H, Gao Y, Li D, et al. WNK3 promotes neuronal survival after traumatic brain injury in rats. Neuroscience. 2021;477:76&#x02013;88.<pub-id pub-id-type="pmid">34626749</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Naqvi</surname><given-names>S</given-names></name><name><surname>Sleyp</surname><given-names>Y</given-names></name><name><surname>Hoskens</surname><given-names>H</given-names></name><name><surname>Indencleef</surname><given-names>K</given-names></name><name><surname>Spence</surname><given-names>JP</given-names></name><name><surname>Bruffaerts</surname><given-names>R</given-names></name><etal/></person-group><article-title>Shared heritability of human face and brain shape</article-title><source>Nat Genet</source><year>2021</year><volume>53</volume><fpage>830</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1038/s41588-021-00827-w</pub-id><pub-id pub-id-type="pmid">33821002</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Naqvi S, Sleyp Y, Hoskens H, Indencleef K, Spence JP, Bruffaerts R, et al. Shared heritability of human face and brain shape. Nat Genet. 2021;53:830&#x02013;9.<pub-id pub-id-type="pmid">33821002</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><mixed-citation publication-type="other">Sha Z, Schijven D, Fisher SE, Francks C. Genetic architecture of the white matter connectome of the human brain. Sci Adv. 2023;9:eadd2870.</mixed-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="other">Belloy ME, Guen YL, Stewart I, Herz J, Sherva R, Zhang R, et al. The role of X chromosome in Alzheimer&#x02032;s disease genetics. JAMA Neurol. 2024;11:2024.04.22.24306094.</mixed-citation></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Gorlov</surname><given-names>IP</given-names></name><name><surname>Amos</surname><given-names>CI</given-names></name></person-group><article-title>Why does the X chromosome lag behind autosomes in GWAS findings?</article-title><source>PLoS Genet</source><year>2023</year><volume>19</volume><fpage>1</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1371/journal.pgen.1010472</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Gorlov IP, Amos CI. Why does the X chromosome lag behind autosomes in GWAS findings? PLoS Genet. 2023;19:1&#x02013;19.</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Seto</surname><given-names>M</given-names></name><name><surname>Hohman</surname><given-names>TJ</given-names></name><name><surname>Mormino</surname><given-names>EC</given-names></name><name><surname>Papp</surname><given-names>KV</given-names></name><name><surname>Rentz</surname><given-names>READM</given-names></name><name><surname>Johnson</surname><given-names>KA</given-names></name><etal/></person-group><article-title>Parental history of memory impairment and &#x003b2;-amyloid in cognitively unimpaired older adults</article-title><source>JAMA Neurol</source><year>2024</year><volume>81</volume><fpage>798</fpage><lpage>804</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2024.1763</pub-id><pub-id pub-id-type="pmid">38884955</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Seto M, Hohman TJ, Mormino EC, Papp KV, Rentz READM, Johnson KA, et al. Parental history of memory impairment and &#x003b2;-amyloid in cognitively unimpaired older adults. JAMA Neurol. 2024;81:798&#x02013;804.<pub-id pub-id-type="pmid">38884955</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Dubal</surname><given-names>DB</given-names></name><name><surname>Elser</surname><given-names>HC</given-names></name></person-group><article-title>&#x003b2;-Amyloid in cognitively unimpaired individuals-blame mom?</article-title><source>JAMA Neurol</source><year>2024</year><volume>81</volume><fpage>795</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1001/jamaneurol.2024.1748</pub-id><pub-id pub-id-type="pmid">38885009</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Dubal DB, Elser HC. &#x003b2;-Amyloid in cognitively unimpaired individuals-blame mom? JAMA Neurol. 2024;81:795&#x02013;7.<pub-id pub-id-type="pmid">38885009</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>